CA2279974C - Radially expandable tubular polytetrafluoroethylene grafts and method of making same - Google Patents

Radially expandable tubular polytetrafluoroethylene grafts and method of making same Download PDF

Info

Publication number
CA2279974C
CA2279974C CA002279974A CA2279974A CA2279974C CA 2279974 C CA2279974 C CA 2279974C CA 002279974 A CA002279974 A CA 002279974A CA 2279974 A CA2279974 A CA 2279974A CA 2279974 C CA2279974 C CA 2279974C
Authority
CA
Canada
Prior art keywords
graft
eptfe
radially
tubular structure
expanded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002279974A
Other languages
French (fr)
Other versions
CA2279974A1 (en
Inventor
Tarun J. Edwin
Fariba Hurry
Christopher E. Banas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bard Peripheral Vascular Inc
Original Assignee
Bard Peripheral Vascular Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25163937&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2279974(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bard Peripheral Vascular Inc filed Critical Bard Peripheral Vascular Inc
Priority to CA002565930A priority Critical patent/CA2565930A1/en
Publication of CA2279974A1 publication Critical patent/CA2279974A1/en
Application granted granted Critical
Publication of CA2279974C publication Critical patent/CA2279974C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/16Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/048Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/022Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the choice of material
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/03Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
    • B29C48/09Articles with cross-sections having partially or fully enclosed cavities, e.g. pipes or channels
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C55/00Shaping by stretching, e.g. drawing through a die; Apparatus therefor
    • B29C55/005Shaping by stretching, e.g. drawing through a die; Apparatus therefor characterised by the choice of materials
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C55/00Shaping by stretching, e.g. drawing through a die; Apparatus therefor
    • B29C55/22Shaping by stretching, e.g. drawing through a die; Apparatus therefor of tubes
    • B29C55/24Shaping by stretching, e.g. drawing through a die; Apparatus therefor of tubes radial
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B1/00Layered products having a general shape other than plane
    • B32B1/08Tubular products
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B27/00Layered products comprising a layer of synthetic resin
    • B32B27/06Layered products comprising a layer of synthetic resin as the main or only constituent of a layer, which is next to another layer of the same or of a different material
    • B32B27/08Layered products comprising a layer of synthetic resin as the main or only constituent of a layer, which is next to another layer of the same or of a different material of synthetic resin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B27/00Layered products comprising a layer of synthetic resin
    • B32B27/32Layered products comprising a layer of synthetic resin comprising polyolefins
    • B32B27/322Layered products comprising a layer of synthetic resin comprising polyolefins comprising halogenated polyolefins, e.g. PTFE
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/06Blood vessels
    • A61F2/07Stent-grafts
    • A61F2002/072Encapsulated stents, e.g. wire or whole stent embedded in lining
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2027/00Use of polyvinylhalogenides or derivatives thereof as moulding material
    • B29K2027/12Use of polyvinylhalogenides or derivatives thereof as moulding material containing fluorine
    • B29K2027/18PTFE, i.e. polytetrafluorethene, e.g. ePTFE, i.e. expanded polytetrafluorethene
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2262/00Composition or structural features of fibres which form a fibrous or filamentary layer or are present as additives
    • B32B2262/02Synthetic macromolecular fibres
    • B32B2262/0253Polyolefin fibres
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B32LAYERED PRODUCTS
    • B32BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
    • B32B2535/00Medical equipment, e.g. bandage, prostheses, catheter

Abstract

Tubular ePTFE materials which are capable of being radially expanded under the influence of a radially outward force applied from the lumen of the ePTFE tubular material to substantially uniformly radially deform the ePTFE
material. The ePTFE material is radially expandable to a diameter 700 %
its unexpanded diameter under the influence of pressures less than 6 atm while retaining the structural integrity of the ePTFE microstructure. Conservation of the structural integrity of the ePTFE material is determined by conservation of the ePTFE microstructure structural integrity.

Description

RADIALLY EXPANDABLE TUBULAR POLYTETRAFLUOROETHYLENE
GRAFTS AND METHOD OF MAKING SAME
Background of the Invention The present invention relates generally to longitudinally expanded microporous S tubular polytetrafluoroethylene grafts, and more particularly, to radially expandable polytetrafluoroethylene ("rePTFE") grafts which are longitudinally expanded and sintered prior to radial expansion. The radially expandable polytetrafluoroethylene grafts of the present invention are particularly well suited for covering an endoluminal prosthesis, being .
endoluminally delivered to a site within a mammalian body, and radially expanded in vivo to restore an anatomical passageway or to create a passageway.
Microporous expanded polytetrafluoroethylene ("ePTFE") tubes may made by any one of different, but well known, methods. Expanded polytetrafluoroethylene is typically made by admixing particulate dry polytetrafluoroethylene resin with a lubricant to form a viscous slurry. The admixture is poured into a mold, typically a cylindrical mold, and compressed under the influence of a positive pre:;sure to form a cylindrical billet. The billet is then ram extruded through an extrusion die into either tubular or sheet structures termed in the art as extrudates. The extrudates consist of extruded polytetrafluoroethylene-lubricant admixture, termed in the art as "wet PTFE." Wet PTFE has a microstructure of coalesced, coherent PTFE resin particles in a highly crystalline state. After extrusion, the wet PTFE is exposed to a temperature below the flash point of the lubricant to volatilize a major fraction of the lubricant from the PTFE ex~rudate. The resulting PTFE
extrudate without a major fraction of lubricant is known in the art as dried PTFE. The dried PTFE is then either uniaxially, biaxially or radially expanded using appropriate mechanical apparatus known in the art. Expansion is typically carried out at an elevated temperature, e.g., above room temperature but below 327 °C, the crystalline melt point of polytetrafluoroethylene.
Uniaxial, biaxial or radial expansion of the dried PTFE causes the coalesced, coherent PTFE resin to form fibrils emanating from nodes, with the fibrils oriented parallel to the axis of expansion. Once expanded, the dried PTFE is referred to as expanded PTFE
("ePTFE") or microporous PTFE. The ePTFE is then transferred to a heating oven and heated to a temperature above 327 °C, the crystalline melt point of PTFE, while restraining the ePTFE
against uniaxial, biaxial radial contraction, to sinter the ePTFE, thereby causing at least a portion of the crystalline PTFE to undergo a physical change from a crystalline structure to S an amorphous structure. The conversion from a highly crystalline structure to an increased amorphous content, which results from sintering, serves to lock the node and fibril microstructure, as well as its orientation relative to the axis of expansion, and provides a dimensionally stable tubular or sheet material upon cooling. Expansion may also be carried out at a temperature below the vapor point of the lubricant. However, prior to the sintering step, the PTFE must be dried of lubricant because the sintering temperature of PTFE is greater than the flash point of commercially available lubricants.
Sintered ePTFE articles exhibit significant resistance to further uniaxial, or radial expansion. This property has lead many in the art to devise techniques which entail endoluminal delivery and placement of an ePTFE graft having a desired fixed diameter, followed by endoluminal delivery and placement of an endoluminal prosthesis, such as a stmt or other fixation device, to fractionally engage the endoluminal prosthesis within the lumen ofthe anatomical passageway. The Kreamer Patent, U.S. Patent No.
5,078,726, issued in 1992, exemplifies such use of an ePTF'E prosthetic graft. Kreamer discloses a method of excluding an abdominal aortic aneurysm which entails providing a tubular PTFE
graft which has a diameter corresponding to that of the inside diameter of a healthy section of the abdominal aorta, delivering the tubular PTFE graft and positioning the graft so that it spans the abdominal aorta. Prosthetic balloon expandable stents are then delivered and placed proximal and distal the abdominal aorta and within the lumen of the tubular PTFE
graft. The prosthetic stents are then balloon expanded to fractionally engage the proximal and distal ends of the tubular PTFE graft against the inner luminal wall of healthy sections of the abdominal aorta.
Similarly, published International Applications No. W095/05132 and W095/05555, both published 23 February 1995, filed by W.L. Gore Associates, Inc., disclose balloon expandable prosthetic stents which have been covered on inner and outer surfaces of the
-2-
3 PCT/US98/02361 stem by wrapping ePTFE sheet material about the balloon expandable prosthetic stent in its enlarged diameter, sintering the wrapped ePTFE sheet material to secure it about the stent, then the assembly is crimped down to a reduced diameter for endoluminal delivery using a balloon catheter. Once positioned endoluminall3~, the stmt-graft combination is then dilatated to re-expand the stent to its enlarged diameter and return the ePTFE
wrapping to its original diameter. Thus, the original unexpended diameter of the ePTFE
wrap delimits diametric expansion of the stent and the ePTFE ~wc~ap is returned to its original uncrimped diameter.
Thus, it is well known in the prior art to ~~rovide an ePTFE covering which is fabricated at the final desired endovascular diameter and is endoluminally delivered in a folded or crimped condition to reduce its delivery profile, then unfolded in vivo using either the spring tension of a self expanding, thermally induced, expanding structural support member or a balloon catheter.
In contradistinction to the prior art, the present invention provides a radially, plastically deformable tubular ePTFE material, h;~ving a microstructure of nodes interconnected by fibrils, with the nodes being substantially perpendicular to the longitudinal axis of the tubular ePTFE material and the fibrils being oriented parallel to the longitudinal axis of the tubular ePTFE material. Radial expansion of the inventive ePTFE
material deforms the ePTFE microstructure by elongating; the nodes while substantially retaining the internodal distances (IND) between adjacent nodes in the longitudinal axis of the ePTFE
tube.
As used herein, the following terms have the intended meanings as indicated.
"Fibril" refers to a strand of PTFE material which originates from one or more nodes and terminates at one or more nodes."
"Internodal Distance" or "IND" refers to an average distance between two adjacent nodes measured along the longitudinal axis of each node between the facing surfaces of the adjacent nodes. IND is expressed in microns (~c) as the unit of measure.

"Node" refers to the solid region within an ePTFE material at which fibrils originate and converge.
"Node Length" as used herein refers to a distance measured along a straight line between the furthermost opposing end points of a single node.
"Nodal Elongation" as used herein refers to expansion of PTFE nodes in the ePTFE
microstructure along the longitudinal axis of a node, or along the Node Length.
"Node Width" as used herein refers to a distance measured along a straight line drawn perpendicular to the longitudinal axis of a node between opposing longitudinal surfaces of a node.
"Plastic Deformation" as used herein refers to the radial deformation of the ePTFE
microstructure under the influence of a radially expansive force which deforms and elongates the Node Length and results in elastic recoil of the ePTFE material less than about 25%.
"Radially Expandable" as used herein to describe the present invention refers to a property of the ePTFE tubular member to undergo radially-oriented Plastic Deformation mediated by Nodal Elongation.
"Structural Integrity" as used herein to describe the present invention refers to a condition of the ePTFE microstructure both pre and post-radial deformation in which the fibrils are substantially free of fractures or breaks and the ePTFE material is free of gross failures.
The inventive ePTFE material of the present invention is capable of being radially expanded under the influence of a radially outward force applied from the lumen of the ePTFE tubular material to substantially uniformly deform the ePTFE material.
The inventive ePTFE material is radially expandable to a diameter 700% its unexpanded
-4-diameter under the influence of pressures less than 6 atm, preferably less than or equal to about 4.0 to 4.5 atm., most preferably between :?-3 atm., while retaining the structural integrity of the ePTFE microstructure. Conservation of the structural integrity of the ePTFE material is determined by conservation of the ePTFE microstructure structural integrity. During and after radial expansion up to an including about 700% of the original unexpended diameter, the ePTFE microstructure: structural integrity is considered conserved where the following factors are met: 1 ) IND rerriains substantially the same as the unexpended graft; 2) water entry pressure as measured by Association for the Advancement of Medical Instrumentation (AAMI) test method 8.2.4 remains within t 60% of the water entry pressure of the unexpended graft; 3) the wall thickness of the graft, as determined by AANII test method 8.7.4, maintains its concentricity as determined by a substantially uniform wall thickness within X30% about the circumference of the graft; 4) average post-radial expansion wall thickness remains within a>r~out t70% of the average pre-radial expansion wall thickness as determined by AAMI test method 8.7.4; 5) longitudinal tensile strength as measured by AAMI test method 8.3.:? remains within t 100% of the value of the unexpended graft, when normalized for wall thickness; 6) radial tensile strength as measured by AAMI test method 8.3.1 remains within ~ 40~% of the value of the unexpended graft, when normalized for wall thickness; and 7) is free of gross tears or fractures.
Summary of the Invention It is a primary objective of the present invention to provide an ePTFE tubular member which is radially expandable in vivo at radial expansion pressures less than about 6 atm, and is suitable for use as a cover or liner for an endoluminal support member, such as a self expanding stent, shape memory stent, or balloon expandable stent.
It is another primary objective of the present invention to provide an ePTFE
tubular member which is capable of being delivered intraluminally into the body in a relatively small diameter and radially expanded in vivo to act as an intraluminal anatomical liner of, for -S-WO 98/33453 PCT/LTS98/0236i example, the vasculature, the alimentary tract, biliary ducts, hepatic-portal vein shunts, or as bypass grafts to carry body fluids around an obstructed flow path.
It is another objective of the present invention to provide a radially expandable ePTFE tubular member which is capable of percutaneous and endovascular delivery to both the coronary and peripheral vasculature in a mammalian body.
It is still another objective of the present invention to provide a radially expandable ePTFE tubular member which, after radial expansion up to about 700% its original diameter, retains its structural integrity.
It is yet another objective of the present invention to provide a radially expandable ePTFE tubular member which, after radial expansion up to about 700% its original diameter, retains the structural integrity of the ePTFE microstructure.
It is still yet another objective of the present invention to provide a radially expandable ePTFE tubular member which, after radial expansion up to about 700%
its original diameter, is characterized by I) IND remains substantially the same as the unexpended graft; 2) water entry pressure as measured by Association for the Advancement of Medical Instrumentation (AANII) test method 8.2.4 remains within t 60% of the water entry pressure of the unexpended graft; 3) the wall thickness of the graft, as determined by AAMI test method 8.7.4, maintains its concentricity as determined by a substantially uniform wall thickness within t30% about the circumference of the graft; 4) average post-radial expansion wall thickness remains within about t70% of the average pre-radial expansion wall thickness as determined by AAMI test method 8.7.4; 5) longitudinal tensile strength as measured by AAMI test method 8.3.2 remains within ~ 100% of the value of the unexpended graft, when normalized for wall thickness; 6) radial tensile strength as measured by AAMI test method 8.3 .1 remains within t 40% of the value of the unexpended graft, when normalized for wall thickness; and 7) is free of gross tears or fractures.

It is another primary objective of the present invention to provide a methad of making a ePTFE tubular member which is radially expandable in vivo at radial expansion pressures less than about 6 atm. and is suitable for use as a cover or liner for an endoluminal support member, such as a self expanding, shape memory, or balloon expandable stent, and which is characterized by any of the foregoing objectives for the radially expandable ePTFE
tubular member.
Brief Description of the Drawings Figure 1 is a perspective, partial cut-away view of a radially expandable ePTFE graft in accordance with the present invention diagrammatically illustrating the pre-radially I 0 expansion microstructure of the ePTFE material.
Figure 2 is a perspective, partial cut-away view of the inventive radially expandable ePTFE graft in its post-expansion diameter diagrammatically illustrating the post-radial expansion microstructure of the ePTFE material.
Figure 3A is a longitudinal cross-sectional view depicting the inventive radially 15 expandable ePTFE graft covering a radially expandable endoluminal stmt, the assembly being depicted mounted on a balloon catheter in its radially unexpanded condition.
Figure 3B is the longitudinal cross-sectional view depicting the inventive radially expandable ePTFE graft covering a radially expandable endoluminal stmt, the assembly being depicted mounted on a balloon catheter in its radially expanded condition.
20 Figure 4 is a process flow diagram illustrating the inventive method for making radially expandable polytetrafiuoroethylene tubes.
Figure SA is a scanning electron photomicrograph of the inner surface of a 3 mm ID
conventional non-radially expanded ePTFE vascular graft at 200X magnification.

Figure SB is a scanning electron photomicrograph of the inner surface of the 3 mm )D conventional non-radially expanded ePTFE vascular graft of Figure SA taken at SOOX
magnification.
Figure SC is a scanning electron photomicrograph of the outer surface of the 3 mm ID conventional non-radially expanded ePTFE vascular graft of Figure SA at magnification.
Figure SD is a scanning electron photomicrograph of the outer surface of the 3 mm m conventional non-radially expanded ePTFE vascular graft of Figure 6A taken at SOOX
magnification.
Figure 6A is a scanning electron photomicrograph of the inner surface of a 3 mm m conventional expanded ePTFE vascular graft radially expanded 3X at 200X
magnification.
Figure 6B is a scanning electron photomicrograph of the inner surface of the 3 mm m conventional expanded ePTFE vascular graft of Figure 6A taken at SOOX
magnification.
Figure 6C is a scanning electron photomicrograph of the outer surface of the 3 mm m conventional expanded ePTFE vascular graft of Figure 6A at 200X
magnification.
Figure 6D is a scanning electron photomicrograph of the outer surface of the 3 mm m conventional expanded ePTFE vascular graft of Figure 6A taken at SOOX
magnification.
Figure 7A is a scanning electron photomicrograph of the inner surface of a 3 mm m conventional expanded ePTFE vascular graft radially expanded 4X at 200X
magnification.
Figure 7B is a scanning electron photomicrograph of the inner surface of the 3 mm m conventional expanded ePTFE vascular graft of Figure 7A taken at 500X
magnification.
_g_ Figure 7C is a scanning electron photomicrograph of the outer surface of the 3 mm m conventional expanded ePTFE vascular graft: of Figure 7A at ZOOX
magnification.
Figure 7D is a scanning electron photomucrograph of the outer surface of the 3 mm 1D conventional expanded ePTFE vascular graft: of Figure 7A taken at SOOX
magnification.
S Figure 8A is a scanning electron photomicrograph of the inner surface of a 3 mm m conventional expanded ePTFE vascular graft radially expanded SX at 200X
magnification.
Figure 8B is a scanning electron photomicrograph of the inner surface of the 3 mm m conventional expanded ePTFE vascular graft of Figure 8A taken at SOOX
magnification.
Figure 8C is a scanning electron photomicrograph of the outer surface of the 3 mm a7 conventional expanded ePTFE vascular graft of Figure 8A at 200X
magnification.
Figure 8D is a scanning electron photomicrograph of the outer surface of the 3 mm m conventional expanded ePTFE vascular graft of Figure 8A taken at SOOX
magnification.
Figure 9A is a scanning electron photomicrograph of the inner surface of a 6 mm m conventional non-radially expanded ePTFE vascular graft at 200X magnification.
Figure 9B is a scanning electron photomicrograph of the inner surface of the 6 mm m conventional non-radially expanded ePTFE vascular graft ofFigure 9A taken at SOOX
magnification.
Figure 9C is a scanning electron photomicrograph of the outer surface of the 6 mm )D conventional non-radially expanded ePTFE vascular graft of Figure 9A at magnification.

Figure 9D is a scanning electron photomicrograph of the outer surface of the 6 mm 1D conventional non-radially expanded ePTFE vascular graft of Figure 9A taken at SOOX
magnification.
Figure 10A is a scanning electron photomicrograph of the inner surface of a 6 mm m conventional expanded ePTFE vascular graft radially expanded 3X at 200X
magnification.
Figure l OB is a scanning electron photomicrograph of the inner surface of the 6 mm m conventional expanded ePTFE vascular graft of Figure 10A taken at SOOX
magnification.
Figure l OC is a scanning electron photomicrograph of the outer surface of the 6 mm >m conventional expanded ePTFE vascular graft of Figure 1 OA at 200X
magnification.
Figure l OD is a scanning electron photomicrograph of the outer surface of the 6 mm ID conventional expanded ePTFE vascular graft of Figure 1 OA taken at SOOX
magnification.
Figure 11 A is a scanning electron photomicrograph of the inner surface of a 6 mm 1D conventional expanded ePTFE vascular graft radially expanded 4X at 200X
magnification.
Figure 11B is a scanning electron photomicrograph of the inner surface of the 6 mm m conventional expanded ePTFE vascular graft of Figure 11 A taken at SOOX
magnification.
Figure 11 C is a scanning electron photomicrograph of the outer surface of the 6 mm m conventional expanded ePTFE vascular graft of Figure 11 A at 200X
magnification.

WO 98/33453 PCTlUS98/02361 Figure I 1D is a scanning electron photomicrograph of the outer surface of the 6 mm >D conventional expanded ePTFE vascular graft of Figure 11 A taken at SOOX
magnification.
Figure 12A is a scanning electron photornicrograph of the inner surface of a 6 mm » conventional expanded ePTFE vascular graft radially expanded SX at 200X
magnification.
Figure 12B is a scanning electron photomicrograph of the inner surface of the 6 mm 1D conventional expanded ePTFE vascular graft of Figure 12A taken at SOOX
magnification.
Figure 12C is a scanning electron photomicrograph of the outer surface of the 6 mm m conventional expanded ePTFE vascular graft of Figure 12A at 200X
magnification.
Figure 12D is a scanning electron photomicrograph of the outer surface of the 6 mm ID conventional expanded ePTFE vascular graft of Figure 12A taken at SOOX
magnification.
Figure 13A is a scanning electron photorrucrograph of the inner surface of a non-radially expanded 3 mm ID inventive rePTFE endoluminal graft ERF 1683 at 200X
magnification.
Figure 13B is a scanning electron photomdcrograph of the inner surface of the non-radially expanded 3 mm ID inventive rePTFE endoluminal graft of Figure 13A
taken at SOOX magnification.
Figure 13C is a scanning electron photomicrograph of the outer surface of the non-radially expanded 3 mm ff~ inventive rePTFE encloluminal graft of Figure 13A
at 200X
magnification.

Figure 13D is a scanning electron photomicrograph of the outer surface of the non-radially expanded 3 mm ID inventive rePTFE endoluminal graft of Figure 13 A
taken at 500X magnification.
Figure 14A is a scanning electron photomicrograph of the inner surface of an inventive rePT'FE endoluminal graft ERF 1683 radially expanded 3X at 200X
magnification.
Figure 14B is a scanning electron photomicrograph of the inner surface of the inventive rePTFE endoluminal graft ERF 1683 of Figure 14A taken at 500X
magnification.
Figure 14C is a scanning electron photomicrograph of the outer surface of the inventive rePTFE endoluminal graft ERF 1683 of Figure 14A at 200X
magnification Figure 14D is a scanning electron photomicrograph of the outer surface of the inventive rePTFE endoluminal graft ERF 1683 of Figure 14A taken at 500X
magnification.
Figure 15A is a scanning electron photomicrograph of the inner surface of an inventive rePTFE endoluminal graft ERF 1683 radially expanded 4X at 200X
magnification.
Figure 15B is a scanning electron photonvcrograph of the inner surface of the inventive rePTFE endoluminal graft ERF 1683 of Figure 15A taken at 500X
magnification.
Figure 15C is a scanning electron photomicrograph of the outer surface of the inventive rePTFE endoluminal graft ERF 1683 of Figure 15A at 200X
magnification.
Figure 15D is a scanning electron photomicrograph of the outer surface of the inventive rePTFE endoluminal graft ERF 1683 of Figure 15A taken at 500X
magnification.
Figure 16A is a scanning electron photomicrograph of the inner surface of an inventive rePTFE endoluminal graft ERF 1683 radially expanded 5X at 200X
magnification.

Figure 16B is a scanning electron photomicrograph of the inner surface of the inventive rePTFE endoluminal graft ERF 1683 of Figure 16A taken at SOOX
magnification.
Figure 16C is a scanning electron photomicrograph of the outer surface of the inventive rePTFE endoluminal graft ERF I 683 of Figure 16A at 200X
magnification.
Figure 16D is a scanning electron photomicrograph of the outer surface of the inventive rePTFE endoluminal graft ERF 1683 of Figure 16A taken at SOOX
magnification.
Figure 17A is a scanning electron photomicrograph of the inner surface of a non-radially expanded 3 mm >D inventive rePTFE endoluminal graft ERF 1687 at 200X
magnification.
Figure 17B is a scanning electron photomicrograph of the inner surface of the non-radially expanded 3 mm ID inventive rePTFE endoluminal graft of Figure 17A
taken at SOOX magnification.
Figure 17C is a scanning electron photomicrograph of the outer surface of the non-radially expanded 3 mm ID inventive rePTFE endoluminal graft of Figure 17A at magnification.
Figure 17D is a scanning electron photomicrograph of the outer surface of the non-radially expanded 3 mm 1D inventive rePTFE endoluminal graft of Figure 17A
taken at SOOX magnification.
Figure 18A is a scanning electron photomicrograph of the inner surface of an inventive rePTFE endoluminal graft ERF 1687 radially expanded 3X at 200X
magnification.
Figure 18B is a scanning electron photomi<;rograph of the inner surface of the inventive rePTFE endoluminal graft ERF 1687 of Figure 18A taken at SOOX
magnification.

Figure 18C is a scanning electron photomicrograph of the outer surface of the inventive rePTFE endoluminal graft ERF 1687 of Figure 18A at 200X
magnification.
Figure 18D is a scanning electron photomicrograph of the outer surface of the inventive rePTFE endolununal graft ERF 1687 of Figure 18A taken at SOOX
magnification.
Figure 19A is a scanning electron photomicrograph of the inner surface of an inventive rePTFE endoluminal graft ERF 1687 radially expanded 4X at 200X
magnification.
Figure 19B is a scanning electron photomicrograph of the inner surface of the inventive rePTFE endoluminal graft ERF 1687 of Figure 19A taken at SOOX
magnification.
Figure 19C is a scanning electron photomicrograph of the outer surface of the inventive rePTFE endoluminal graft ERF 1687 of Figure 19A at 200X
magnification.
Figure 19D is a scanning electron photomicrograph of the outer surface of the inventive rePTFE endoluminal graft ERF 1687 of Figure 19A taken at SOOX
magnification.
Figure 20A is a scanning electron photomicrograph of the inner surface of an inventive rePTFE endoluminal graft ERF 1687 radially expanded SX at 200X
magnification.
Figure 20B is a scanning electron photomicrograph of the inner surface of the inventive rePTFE endoluminal graft ERF 1687 of Figure 20A taken at SOOX
magnification.
Figure 20C is a scanning electron photomicrograph of the outer surface of the inventive rePTFE endoluminal graft ERF 1687 of Figure 20A at 200X
magnification.
Figure 20D is a scanning electron photomicrograph of the outer surface of the inventive rePTFE endoluminal graft ERF 1687 of Figure 20A taken at SOOX
magnification.

Figure 21 A is a scanning electron photonnicrograph of the inner surface of a non-radially expanded 3 mm m inventive rePTFE endoluminal graft ERF 1689 at 200X
magnification.
Figure 21B is a scanning electron photonlicrograph of the inner surface of the non-radially expanded 3 mm ID inventive rePTFE endoluminal graft of Figure 21 A
taken at SOOX magnification.
Figure 21C is a scanning electron photonucrograph of the outer surface of the non-radially expanded 3 mm ID inventive rePTFE endoluminal graft of Figure 21 A at magnification.
I 0 Figure 21D is a scarming electron photomicrograph of the outer surface of the non-radially expanded 3 mm 1D inventive rePTFE endoluminal graft of Figure 21 A
taken at SOOX magnification.
Figure 22A is a scanning electron photorrucrograph of the inner surface of an inventive rePTFE endoluminal graft ERF 1689 radially expanded 3X at 200X
magnification.
1 S Figure 22B is a scanning electron photomncrograph of the inner surface of the inventive rePTFE endoluminal graft ERF 1689 o:F Figure 22A taken at SOOX
magnification.
Figure 22C is a scanning electron photomncrograph of the outer surface of the inventive rePTFE endoluminal graft ERF 1689 o~E Figure 22A at 200X
magnification.
Figure 22D is a scanning electron photonrucrograph of the outer surface of the 20 inventive rePTFE endoluminal graft ERF 1689 oi" Figure 22A taken at SOOX
magnification.
Figure 23A is a scanning electron photomucrograph of the inner surface of an inventive rePTFE endoluminal graft ERF 1689 ra.dially expanded 4X at 200X
magnification.

Figure 23B is a scanning electron photomicrograph of the inner surface of the inventive rePTFE endoluminal graft ERF 1689 of Figure 23A taken at SOOX
magnification.
Figure 23C is a scanning electron photomicrograph of the outer surface of the inventive rePTFE endoluminal graft ERF 1689 ofFigure 23A at 200X
magnification.
Figure 23D is a scanning electron photomicrograph of the outer surface of the inventive rePTFE endoluminal graft ERF 1689 of Figure 23A taken at SOOX
magnification.
Figure 24A is a scanning electron photomicrograph of the inner surface of an inventive rePTFE endoluminal graft ERF 1689 radially expanded SX at 200X
magnification.
Figure 24B is a scanning electron photomicrograph of the inner surface of the inventive rePTFE endoluminal graft ERF 1689 of Figure 24A taken at SOOX
magnification.
Figure 24C is a scanning electron photomicrograph of the outer surface of the inventive rePTFE endoluminal graft ERF 1689 of Figure 24A at 200X
magnification.
Figure 24D is a scanning electron photomicrograph of the outer surface of the inventive rePTFE endoluminal graft ERF 1689 of Figure 24A taken at 500X
magnification.
Detailed Descriution of the Preferred Embodiments In accordance with the preferred embodiments of the present invention there is provided a longitudinally expanded polytetrafluoroethylene tubular member having a continuous substantially concentric wail surface which has no seam and which is radially deformable between about SO% to about 700% its original diameter with application of a radially directed outward pressure of less than about 6 atm, preferably less than or equal to about 4 to 4.5 atm without loss of structural integrity. Structural integrity is considered retained where the microstructure of the ePTFE after radial expansion, is substantially free of broken or fractured fibrils and where the following factors are met: 1 ) IND remains substantially the same as the unexpended graft; 2) water entry pressure as measured by Association for the Advancement of Medical Ins~:rumentation (AAMI) test method 8.2.4 remains within t 60% of the water entry pressurE; of the unexpended graft; 3 ) the wall thickness ofthe graft, as determined by AAMI test method 8.7.4, maintains its concentricity as determined by a substantially uniform wall thickness within t30% about the circumference of the graft; 4) average post-radial expansion wall thickness remains within about t70% of the average pre-radial expansion v~aIl thickness as determined by AANII test method 8.7.4; 5) longitudinal tensile strength as measured by AAMI test method 8.3.2 remains within ~ 100% of the value of the unexp~mded graft, when normalized for wall thickness; 6) radial tensile strength as measured ~~y AAMI test method 8.3.1 remains within t 40% of the value of the unexpended graft, when normalized for wall thickness; and 7) is free of gross tears or fractures.
As is well known in the art, longitudinally expanded polytetrafluoroethylene (ePTFE) tubular structures may be made by ram extruding a compressed billet of polytetrafluoroethylene resin and a lubricant extnision aid through an annular orifice formed by an extrusion die and a mandrel to form a tubular extrudate. The tubular extrudate is free of seams, overlaps, crimps, folds, or the like. Wl:ule the tubular extrudate still contains the lubricant it is referred to as being "wet." The wel: extrudate lacks dimensional stability, is easily damaged, and is difficult to manipulate or otherwise process without removing the lubricant. Typically lubricant is removed and the extrudate "dried" by heating the wet extrudate to a temperature below the flash point of the lubricant and below the crystalline melt temperature of the PTFE resin which volatilizes the lubricant from the PTFE resin.
Dimensional stability and the degree to which the extrudate may be manipulated or processed is related to the concentration of lubricant in the extrudate. Thus, the extrudate may be partially or fizlly dried, depending upon the residual lubricant concentration desired, by varying the dwell or residence time of the wet extrudate in the drying oven.
Once the extrudate is dried to the extent desired, the dried extrudate is longitudinally expanded at a temperature below the crystalline melt temperature of the PTFE
resin.

Longitudinal expansion is performed at a rate of between about 5%/sec. to about 800%/sec.
with the final expansion ratio being between 2:1 to 6:1. The ends of the longitudinally expanded PTFE are constrained against shortening and the ePTFE is exposed to a temperature above the crystalline melt temperature of the PTFE resin for a period of time to S sinter the PTFE and amorphously lock the node-fibril microstructure and stabilize the porosity of the ePTFE tubular structure.
Figure 1 depicts a radially expandable ePTFE tubular member 10 in accordance with the present invention. The inventive ePTFE tubular member 10 has an inner diameter d and is shown with a portion of its outer surface cut away and microscopically enlarged to illustrate the ePTFE microstructure 12. The ePTFE microstructure consists of a plurality of nodes 14 interconnected by a plurality of fibrils 16. The plurality of fibrils I 6 emanate from and converge to the plurality of nodes 14 spanning the internodal distance a.
The plurality of nodes 14 are each substantially solid, have a node length b which is generally perpendicular to the longitudinal axis of the ePTFE tubular member 10 and parallel with the transverse axis of the ePTFE tubular member 10.
Figure 2 depicts the same tube depicted in Figure 1 which has been radially expanded to a larger diameter d'. Radial expansion is accomplished, for example, by introducing a balloon catheter into the lumen of the ePTFE tubular member 10, introducing a pressurized fluid into the balloon catheter, thereby causing the catheter balloon to expand and exert a positive pressure directed radially outward from the lumen of ePTFE tubular member 10, which, in turn, radially deforms ePTFE tubular member 10 to a larger diameter.
Radial deformation of the ePTFE tubular member 10 is mediated by elongation of the plurality of nodes 14 to an elongated node length b' in the region of the ePTFE tubular member 10 where the positive pressure is exerted by the catheter balloon. As illustrated in Figure 2 the entire ePTFE tubular member 10 is radially deformed to the larger diameter d'.
One notable physical feature of the present invention is the elongation of the plurality of nodes 14 along their longitudinal axis while the post-expansion average internodal distances a' remains substantially the same as the internodal distance a of the non-radially deformed ePTFE tubular member 10.

It will be understood, by those skilled in the art, that the radially deformable ePTFE
tubular member 10 of the present invention is particularly well suited for use as a covering or liner for an endoluminal stent. Endoluminal stents are generally of three types. Balloon expandable endoluminal stents require the application of a positive pressure to the stent to radially deform the stent beyond the elastic limit of the material used to make the stent.
Balloon expandable stents are represented in the art by PALMAZ patents. Self expanding endoluminal stents are made with a configuration which takes advantage of the elastic properties of the stent material and are radially constrained by a restraining sheath during endoluminal delivery and undergo elastic expansion to their unconstrained diameter when the restraining sheath is removed. Self expanding stents are represented in the art by the GIANTURCO or WALLSTEI~'T. Finally, shape memory scents are made of shape memory materials, such as nickel-titanium alloys known as NITINOL, which expand upon exposure to a temperature differential, e.g., expands at body temperature. Any of the foregoing endoluminal stent types may be covered, lined or encapsulated by the inventive radially deformable ePTFE tubular member 10 and radialIy expanded either in vivo or in vitro.
Figures 3A and 3B illustrate the inventive radially expandable ePTFE material encapsulating an endoluminal stent 20, as more fully described in commonly assigned, co-pending application published as PCT International Application W096/28115, published 19 September, 1996, claiming priority from U.S. Patent Nos. 5,749,880 and 6,124,523.
Figure 3A illustrates an encapsulated stent graft 20 in its pre-radially expanded diameter, while Figure 3B illustrates an encapsulated stent graft 30 in its post-radially expanded diameter. The encapsulated stent graft assembly, consisting generally of radially expandable ePTFE material 10 and endoluminal stent 20, are concentrically positioned about a catheter balloon 34 mounted on the distal end of a balloon catheter 32. The catheter balloon 34 defines an inflation chamber 36 therein which receives a pressurized inflation fluid (not shown) from a external source (not shown).
When the pressurized inflation fluid is introduced into the inflation chamber 36, an outwardly directed radial force is exerted substantially uniformly against the luminal surface of the stent graft assembly, thereby urging the stent-graft assembly from its smaller delivery diameter to a '' -19 -larger final diameter depicted in Figure 3B. During dilatation of the catheter balloon 34, the rePTFE material 10 undergoes a substantially plastic deformation transverse to the longitudinal axis of the tubular ePTFE material 10. The positive pressure exerted by the pressurized inflation fluid exerts a radially outward positive pressure to the luminal surface of the radially deformable ePTFE which is oriented substantially parallel to the longitudinal axis of the plurality of nodes in the ePTFE microstructure. The plurality of nodes in the ePTFE microstructure undergo substantially plastic deformation and elongate along their longitudinal axis, thus causing the radial deformation of the ePTFE tubular material 10.
Figures 5A-5D are scanning electron micrographs taken at 200X and 500X
magnification of the inner and outer surfaces of a standard ePTFE vascular graft (Lot 34391, IMPRA, Inc., Tempe, Arizona). It will be noted that the node-fibril microstructure of the ePTFE is characterized by irregular node patterns and fibrils which are substantially cylindrical as reflected by the substantially parallel surfaces along the longitudinal axis of each fibril.
Figures 6A-6D are scanning electron micrographs taken at 200 and 500X
magnification of the inner and outer surfaces of the standard ePTFE vascular graft of Figures 5A-5D which has been radially expanded 3X to an inner diameter of 9 mm. Figures 7A-7D are scanning electron micrographs of the inner and outer surfaces of the standard ePTFE vascular graft of Figures 5A-SD which has been radially expanded 4X to an inner diameter of 12 mm. Figures 8A-8D are scanning electron micrographs of the inner and outer surfaces of the standard ePTFE vascular graft of Figures 5A-5D which has been radially expanded 4X to an inner diameter of 15 mm. From this series of micrographs, it will be observed that the nodes have a largely irregular elongate appearance and are asynchronously arrayed in the microstructure. While average outer surface internodal distance of the base graft is 33~c, at 3X is 33~, at 4X is 32,u and at SX is 33~, the micrographs illustrate that the INDs have a non-uniform distribution throughout the material matrix. Morphologically, it will be seen that radial expansion of the conventional lluVIPRA ePTFE vascular graft results in elongation and thinning of the nodes, which remain irregular in shape, but the INDs continue to have a non-uniform distribution in the material matrix. Figures 9A-D are micrographs of inner ~md outer surfaces of a non-radially expanded 6 mm 1D PTFE graft (Lot No. 34396, 1MPRA, Inc., Tempe, Arizona).
Figures 10A-1 OB are scanning electron micrographs taken at 200 and SOOX magnification of the inner and outer surfaces of the standard ePTFE vascular graft of Figures 9A-9D
which has been radially expanded 3 X to an inner diameter of 18 mm. Figures 11 A-1 I D
are scanning electron micrographs of the inner and outer surfaces of the standard ePTFE
vascular graft of Figures 9A-9D which has been radially expanded 4X to an inner diameter of 24 mm.
Figures 12A-12D are scanning electron microgra;~hs of the inner and outer surfaces of the standard ePTFE vascular graft of Figures 9A-9D which has been radially expanded SX to an inner diameter of 30mm. From this series of micrographs, it will be observed that, like the 3 mm standard PTFE graft, the nodes have a largely irregular elongate appearance and are asynchronously arrayed in the microstructure. While average outer surface internodal distance of the base graft is 33~c, at 3X is 31~c, at 4X is 33~ and at 5X is 33~, the micrographs illustrate that the INDs have a non-uniform distribution throughout the I 5 material matrix. Morphologically, it will be seen that radial expansion of the conventional >'MPRA ePTFE vascular graft results in elongation and thinning of the nodes, which remain irregular in shape, but the INDs continue to have a non-uniform distribution in the material matrix.
In contrast to the standard PTFE graft material, the inventive rePTFE
material, represented herein by ERF 1683, ERF 1687 and ERF 1689, shown in their non-radially expanded base state, and at 3X, 4X and SX radial expansion, in Figures 13A-24C, is characterized by a lower node density and lower fibril density in the unexpended and expanded graft material. Scanning electron microscopy was performed on a JEOL-Scanning Electron Microscope and the accompanying micrographs were obtained during scanning electron microscopy. The lower node density is the result of elongation of the nodes as the graft radially expands, while the lower fibril density is the result of increasing interfibril distances due to the nodal elongation. "Interfibril distance" is the perpendicular distance between any two parallel and adjacent fibrils. The nodes in the inventive rePTFE
material are characterized by a more uniform regular elongate shape which, during radial expansion, undergo a more regular nodal elongation than that exhibited by the standard PTFE graft material, and fibrils which have a torroidal or "necked" profile.
Additionally, as reflected in the accompanying figures, the rePTFE microstructure is characterized by increased tortuosity of the pores than that exhibited by the standard PTFE
graft material.
By an examination of the accompanying electron micrographs at Figures 13A-24C, it will be seen that the base unexpended graft has average INDs of approximately 18.2 .
The plurality of fibrils have a generally torroidal shape along their longitudinal axis, with the intermediate area of each of the plurality of fibrils having a narrower width than the area at either end of the plurality of fibrils 16 adjacent the nodes which the fibrils connect. The plurality of nodes exhibit a substantially parallel array with the nodes being substantially co-axially aligned in end-to-end fashion along the transverse axis of the graft material.
The electron micrographs at Figures 14A-14D, 18A-18D, and 22A-22D, taken of ERF 1683, ERF 1687 and ERF 1689, respectively, radially expanded 3X, illustrate that at 3X expansion the INDs remain substantially the same as the unexpended graft IND of Figures 13A-13D, 17A-17D and 21A-21D, respectively. Additionally, the plurality of l 5 nodes retain their co-axial array as in the unexpended graft material, but are longitudinally deformed along their longitudinal axis and parallel to the axis of radial expansion. The longitudinal profile of the plurality of fibrils also remains generally torroidal in shape. It will be noted, however, that the profile of each of the plurality of nodes has been markedly altered, but in a non-linear manner relative to the degree of gross radial deformation of the ePTFE material itself. After radial deformation, each of the plurality of nodes 14 exhibits an elongated and narrowed profile. Starting at 3X expansion, it becomes apparent that the fibril density in the inventive rePTFE material is greater than that of the conventional ePTFE
material and that the fibrils exhibit a more tangled or tortuous appearance than that found in the conventional ePTFE material.
The electron micrographs at Figures 15A-15D, 19A-19D and 23A-23D, taken of ERF 1683, ERF 1687 and ERF 1689, respectively, radially expanded 4X, illustrate that at 4X expansion the IlVDs remain substantially the same as the unexpended graft IND of Figures 13A-13D, 17A-17D and 21A-21D, respectively. At 4X radial expansion the increased tortuosity of the fibrils becomes even more apparent in the accompanying figures.
While the interfibr~il distance continues to increase, the electron micrographs reflect that the each interfibrilar space is bounded in the z-axis by another fibril in close proximity to the interfibrilar space, which imparts the increased tortuosity of the rePTFE
microstructure.
At SX radial expansion, illustrated with reference to the electron micrographs at Figures 16A-16D, 20A-20D and 24A-24D, taken of taken of ERF 1683, ERF 1687 and ERF 1689, respectively, the interfibril distance has increased relative to both the base graft, or the rePTFE graft at 3X or 4X radial expansion, while the IND remains substantially the same as that of the base rePTFE graft or that at ?~X or 4X radial expansion.
Additionally, the nodes have again elongated along the axis of radial expansion to form long, columnar nodes which have a generally regular distribution throughout the microstructure wherein a substantial majority of the nodes are separated by substantially uniform INDs.
Radially deformable, longitudinally expanded PTFE tubular graft members meeting the criteria of the present invention are made by the method 50 for making radially expandable PTFE tubes illustrated generally in Figure 4. In accordance with the inventive method the general method steps consist of providing a polytetrafluoroethylene resin 51 preferably having an average molecular weight about 120 Million and an average particle size between 350 and 750 ~c, and an extrusion lubricant 52, such as ISOPAR H
(Exxon Chemical), and admixing the PTFE resin and lubricant at step 53. It is preferable that the lubricant be present in the admixture at a ratio of between about 13 .5% to about 18% by weight. The PTFE-lubricant admixture is refiigenated overnight, then is formed into an extrusion billet by pouring the PTFE-lubricant admixture into an upright vertical stainless steel cylinder having a central co-axial vertical pr~~form shaft therein. The vertical stainless steel cylinder is a billet preform which has a diameter corresponding to a diameter of an extrusion barrel in a ram extruder used to extrude; the billet. For example, if the ram extruder has an extrusion barrel inner diameter of 3.81 cm, it is desirable for the extrusion billet to have an outer diameter no greater than 3.81 cm. Thus, it is preferable to match the inner diameter of the billet preform to the inner diameter of the extrusion barrel. Once the PTFE-lubricant admixture is poured into the upria;ht vertical billet preform, an annular ram plate is engaged over the central co-axial vertical shaft and within the billet preform. A ram press is then engaged onto the annular ram plate and the PTFE-lubricant admixture is compressed under pressure until a compacted extrusion billet is formed at step 54. The extrusion billet produced at step 54 is then removed from the billet preform and the preform shaft and engaged upon an extrusion shaft and extrusion mandrel and introduced into the extrusion barrel of a ram extruder. The billet is then extruded at step 55 in a ram extruder having an annular extrusion orifice formed between the inner diameter of the extrusion die and the extrusion mandrel tip concentrically engaged within the extrusion die.
To form PTFE tubes, the extrusion die has a frustroconical taper with a conical taper along the axis of extrusion. A mandrel tip is engaged onto the extrusion shaft at its distal end along the axis of extrusion. The mandrel tip also has a conical taper along the axis of extrusion. The degree to which the PTFE extrusion billet is reduced in cross-sectional area as it passes during extrusion is known as the "reduction ratio" and is expressed by the following equation:
~( Dbarrel \2 _~( Dahaft '2 D . 2 D z ( die ~ _~( mandrel in which RR is the reduction ratio, Dbarel is the inner diameter of the extruder barrel, Ds,,~ is the outer diameter of the extrusion shaft, Dde is the inner diameter of the exit orifice of the extrusion die and D,~a~del is the outer diameter of the extrusion mandrel at its distal end relative to the axis of extrusion.
As the tubular PTFE is extruded, it issues from the die exit orifice as a continuous tubular PTFE extrudate and is cut using a sharp razor blade into any length desired, e.g., 30 cm lengths. The PTFE tubular extrudate lengths are then introduced into an oven at a temperature below the flash point of the lubricant, for example at 40°
C for ISOPAR H
(Exxon Chemical), for a period of time sufficient to drive off and dry, at step 56, substantially all of the lubricant present in the PTFE tubular extrudate, for example, for about 60 minutes. Once the PTFE tubular extrudate is dried of lubricant, expansion plugs are secured into the tube lumen at each opposing end of the PTFE tubular extrudate length, and the plugged PTFE tubular extrudates are mounted onto an expansion rack.
The expansion rack is designed to be mounted into an expansion oven and has a gear, screw, or rail driven moveable stage to which one end of the PTFE tubular extrudate is attached and a S stationary stage to which another end of the PTFIE tubular extrudate is attached. The PTFE
tubular extrudate, mounted on the expansion rack;, is introduced into an expansion oven heated to a temperature below the second crystall~,ine melt point of PTFE, preferably between 125 and 340 °C, most preferably between 150 and 200 °C, and allowed to dwell in the expansion oven for a period of time between 5 and 10 minutes, preferably about 7-8 minutes, before longitudinally expanding the PTF:E tubular extrudate.
Longitudinal expansion of the tubular PTFE extrudates at step 57 is performed after the dwell time for the PTFE extrudates has elapsed. Wide variation in the expansion rate for making different ePTFE products is known. However, in order to impart increased ability of the inventive rePTFE to radially expand at applied pressures of less than about 6 atm., it is preferable that the longitudinal expansion be performed at a rate between about I O and 200%/sec.
After the PTFE extrudates have been longitudinally expanded at step 57, and prior to sintering the PTFE extrudates, the unsintered F'TFE extrudates may either be concentrically laminated with other larger or smaller diameter unsintered PTFE
extrudates, or may be concentrically positioned about luminal and abluminal surfaces of an endoluminal stent at step 58. An endoluminal stmt, which ma.y be a balloon expandable, self expandable or a shape memory stmt, may be introduced at step 59 by concentrically positioning an endoluminal stmt around a first unsintered PTFE extrudate, then a second unsintered PTFE extrudate of a slightly larger inner diameter may be introduced concentrically around the first unsintered PTFE a};trudate and the endoluminal stmt, as more fully described in co-pending PCT International Application W096/28115, published 19 September, 1996, claiming priority from co-pending U.S. Patent Applications Serial Nos. 08/401,871 filed March 10, 1995 and 08/SOF~,033 filed July 27, 1995, which are expressly incorporated by reference as exemplifying a process for making an encapsulated stent graft.
If the introduction of a stmt is not desired, or if the stmt is to be positioned along only a particular longitudinal section of a PTFE extrudate, the PTFE tubular extrudates concentrically positioned relative to one another are then laminated by application of a helically applied tension wrap of non-porous PTFE tape which applies a circumferential pressure to the concentrically positioned laminated tubular PTFE extrudates and/or to the concentrically positioned laminated tubular PTFE extrudates and stent assembly at step 60.
The wrapped assembly, either a laminated tubular PTFE extrudate assembly or a laminated tubular PTFE extrudate and endoluminai stent assembly, is then introduced into a sintering oven set to heat the wrapped assembly to a temperature above the second transition crystalline melt point of PTFE, i.e., above 342 °C, preferably 375 °C +10 -5, for a period of time sufficient to fully sinter the PTFE laminated assembly. In order to increase the bond strength between adjacent PTFE layers in the laminated tubular PTFE
extrudate assembly or the laminated tubular PTFE extrudate and endoluminal stmt assembly, it has been found desirable to utilize a sintering oven having a radiant heating source and sinter the wrapped assembly between 8 to 12 minutes. Alternatively, the wrapped assembly may be sintered in a convection oven for a period of time preferably between 45 and 90 seconds, most preferably between 60 and 90 seconds.
After being removed from the sintering oven and allowed to cool, the helical wrap of PTFE table is removed from the wrapped assembly and the assembly is inspected for material characterization and defects, then sterilized for physiological use.
Table 1, below, summarizes the preferred processing parameters used for making the inventive rePTFE tubular grafts which exhibit up to 700% radial expandability at applied pressures of less than about 6 atm, preferably less than or equal to about 4 atm., most preferably between 2-3 atm.

ERF 1683 ; EP:F 1687 ERF 1689 . ERF~"~,P

I
Resin Type ~ CD 123 CD 123 Resin Amt (g) S00 500 500 ~ 500 Lube Amt. (g) 87 87 100 110 Reduction Ratio I 239 ~ 23~) 239 ~ 239 i Expansion Ratio 5.3:1 ! 5.3:1 6:1
5.3:1 Expansion Rate (%/sec) 10 200 i 200 I 200 ~

Expansion Temp. (C) 340 ; 200 ! 150 ~ 340 ~

I Expansion Time (min) 5 ~ 7 ! 5 ! 5 I

Sintering Temp. (C) 375 i 367 ~ ! 375 ! 37~~ I

Sintering Time (sec) i 60 ~ 60 G

LExpansion 2.3 ~ 0.12n/a Pressure f (atm) .
2.8 t 0.1 ~
2.6 ~
0.28 The following examples set forth the proceoiures used in making the rePTFE
grafts summarized in Table 1, above.

A 3 mm inner diameter (ID) radially expandable ePTFE tube was fabricated by admixing SOOg of CD-123 PTFE resin (ICI Americ~~s, Inc.) with 87g of ISOPAR H
(Exxon Chemicals), yielding a 17.4% lubricant level ("Lube Level") in the admixture.
The admixture was mixed by rolling in a glass container, then incubated at 40 ° C for 6 to 8 hours. After incubation, the admixture was poured into a cylindrical pre-form having an inner diameter of 3.81 cm. And compressed in a veuical ram press at about 1,100 psi to form a cylindrical extrusion billet. The extrusion billet was carefully removed from the cylindrical pre-form, wrapped in aluminum foil and incubated prior to use.
The extrusion billet was mounted onto a cylindrical stainless steel base shaft having a diameter of 0.357 cm which passed through the cE:ntral longitudinal axis of the extrusion billet and projected beyond both ends of the extrusion billet. A tapered extrusion mandrel has a proximal end which is coupled to the base shaft and has proximal end diameter of 0.357cm and tapers to a mandrel tip at the distal end of the mandrel which has an outer diameter of 0.335 cm. The extrusion billet was then mounted in the extrusion barrel of a ram extruder, the extrusion barrel having an inner diameter of 3.81 cm, and a tapered extrusion die having an entry opening inner diameter of 3.81 cm tapering to a circular exit orifice of 0.412 cm inner diameter. The mandrel tip is co-axially aligned to pass centrally into the circular exit orifice of the extrusion die forming an annular exit orifice. The annular exit orifice is defined between the inner surface of the circular exit orifice of the extrusion die and the outer surface of the mandrel tip and forms an opening having a thickness of 0.076 cm. The extrusion billet is then extruded in the ram extruder at an extrusion speed of .
3000 mm/min to yield a wet tubular extrudate. The wet tubular extrudate is cut using a razor blade into 30 cm sections as it issues from the extrusion die.
Cylindrical stainless steel expansion plugs are inserted into the opposing ends of the wet tubular extrudate and secured by crimping a metal band about the outer surface of the wet tubular extrudate to create an interference fit between the crimped metal band, the PTFE wet tubular extrudate and the plug, as more fully explained in U.S.
Patent No.
5,453,235, which is hereby incorporated by reference for the procedure of affixing the plugs to the tubular extrudate.
The wet tubular extrudate is then mounted onto a drying and expansion rack and introduced into a pre-heated oven at 40 ° C for 60 minutes to dry the lubricant from the PTFE resin. The dried tubular extrudate is then allowed to dwell in an oven heated to 340 ° C, then longitudinally expanded at an expansion rate of 200%/sec for an overall longitudinal expansion ratio of 530%. The longitudinally expanded extrudate is then sintered at 375 °C for 60 seconds and removed from the sintering oven, removed from the drying and expansion rack, hung vertically and allowed to cool.
After cooling, the expansion plugs and crimp bands are removed from the ePTFE
tubes and sterilized in ethylene oxide. The 3 mm inner diameter radially expandable tubes produced in the Example 1 tube are hereinafter referred to as lot ERF 1683.

EXAMPI:.E 2 The same processing parameters were followed in as in Example I , except that the expansion rate was changed to 10%/sec. 3 mm inner diameter radially expandable tubes produced in Example 2 are hereinafter referred to as lot ERF 1687.

The same processing parameters were followed as in Example 1, except that the lubricant amount was changed to 1008 yielding a tube level of 20%. The 3 mm inner diameter radially expandable tubes produced in Example 3 are hereinafter referred to as lot ERF 1689.

The same process parameters were followed as in Example 1, except that the lubricant amount was changed to 1 l Og, yielding a Tube level of 22%, the expansion ratio was changed to 6: l, the PTFE extrudate was allowed to dwell in the expansion oven for 7 minutes prior to expansion and the expansion was conducted at 200 °C.
The resulting 3 mm inner diameter radially expandable tubes produced in Example 4 are hereinafter referred to as lot ERF~,~ap.

One 3 mm and one 4 mm 1D unsintered tube produced in accordance with the process in Example 4 were obtained. A 3mm inner diameter (m) unsintered tube was loaded onto a 3.56 mm mandrel. Opposing end sections of the tube were wrapped with TEFLON tape to prevent slippage on the mandre,~. Next, two P-394 "PALMAZ"
stems and two P-308 "PALMAZ" stems were pre-dilated on a 4.74 mm mandrel. The pre-dilated stems were then loaded over the 3 mm ePTFE tube and spaced equidistantly from one another along the length of the 3 mm ePTFE graft. The pre-dilated stems were then crimped down onto the mandrel and the outer surface of the 3 mm ePTFE graft.
Next, a 4 mm m graft was loaded over the crimped stems. The 4 mm ePTFE graft was wire wrapped onto the assembly at its ends and between the crimped stents.
Subsequent to the loading steps, the wrapped assembly was then warmed in a radiant heat oven at 340° C for 30 seconds and then removed. The entire assembly was then wrapped with TEFLON
tape using a helical winder set to apply the winding at 1.7 psi. The wrapped assembly was then placed in a radiant heat sintering oven preheated to 400 ° C and heated at sintering temperatures of 367° C for a total of 8 minutes. The TEFLON taped assembly was then removed from the oven and the TEFLON tape and wire wraps were removed. The ePTFE
grafts were then cut about one inch outside of each of the ends of the stents.
Finally, the resulting encapsulated stems were gently removed from the mandrel one at a time and then cut to provide a 3 mm ePTFE overhang at both ends of the individual stems.
Sintering in a radiant heat oven for longer periods of time than in a convection oven was found to increase the bond strength of the laminated PTFE layers in the encapsulated stent.
Ten encapsulated stents were tested for bond strength between the inner and outer ePTFE layers of the encapsulated stmt. The bond strength testing was quantified by performing longitudinal peel tests on an INSTRON tester and formalizing for adhesion strength per unit length. Each encapsulated stmt was cut into two strips (A &
B) with each strip being approximately 5.5 mm wide and 25.4 mm long. Opposing surfaces on the encapsulated stent strips were each attached to an INSTRON tester and the tester actuated to peel the strips. Table 2, below, summarizes the results of the peel test and reflects the bond strength of the samples tested.

Run Std. Dev.
~
Average Bond Strength (A&B) [n=IO]
g/mm 1 24.735 0.0332 2 28.917 0.0511 3 21.688 0.0379.

4 19.648 0.0447 5 17.168 0.0220
6 ~ 26.543 0.0163
7 ~ 20.I78 ~ 0.0306
8 ~ 20.270 0.0541
9 l 37.245 ~
0.0397 Physical and Structural Characterization Test Procedures The physical and structural test data obtained from testing material obtained from each of the foregoing examples is set forth in Tables 3-8, below. The tests used to generate 1 S the data are based upon the standards developed by the Association for the Advancement of Medical Instrumentation (AAMI) and published in the document entitled "Cardiovascular Implants - Vascular Prostheses" and are also approved by the American National Standards Institute (ANSI). The following describes the specific test procedures used to generate the following physical and structural characterization on the inventive radially expandable ePTFE endoluminal gaff.
Wall Thickness (Wl~.
(a) Base Graft: This test was performed on an optical microscope equipped with a vernier stage and eyepiece cross hairs. A 2 cm segnnent was cut from the graft and mounted on a glass slide with the cut end parallel to the lens. Four measurements of the wall were taken on the circumference 90 ° apart, and averaged for the representative wall thickness.

(b) Expanded Graft: The above procedure could not be used because the graft material was too thin to be stood upright. Accordingly, a calibrated constant pressure thickness gauge, or snap gauge, was used. A 2cm segment of the expanded graft sample was flattened on a board and three measurements were taken from different areas of the sample. These values were then divided by 2 to obtain the individual wall thickness and then averaged for the reported wall thickness.
Radial Tensile Strength (RTS).
A 1 cm graft segment is mounted onto vice radial-fixtures on an INSTRON
tensile tester. The sample is then pulled radially at a rate of 1 in/min to elongate the internal diameter until failure occurs. The peak force is noted and the RTS value is calculated according to the following equation:
(16.13)( F) RTS=
WT.
where Fp is the recorded peak force in lbs and WT; is the initial wall thickness of the sample and the RTS value is expressed in psi units.
Internodal Distance (IND).
IND measurement is an evaluation of the node-fibril microstructure of the ePTFE
graft. A 1 cm graft segment is cut longitudinally and the sample is flattened into a sheet.
The surface to be studied is placed face up on a glass slide prepared with double sided tape.
The surface is colored using a contrast dye such as aniline dye. Using an optical microscope with a calipered stage and reticle, the average distance between 2 adjacent nodes is recorded. Three measurements are taken per sample for each side. These readings are then averaged for each of the inner surface (IND;) and the outer surface (INDo) of the ePTFE
graft and are expressed in ~c or 1 x 10-6 meters.

Water Entry Pressure (WEP). Water entry pressure is an indirect measurement of the porosity of the graft which uses pressurized water to evaluate the graft's ability to retain fluid under pressure. Botl'n ends of a 9cm graft sample are securely clamped with hemostats. A 22 gauge hypodermic needle is then introduced at a 45 ° angle through the graft wall land into the lumen. The graft is then slowly filled with distilled water until the internal water pressure reaches 0.'B to 1.8 psi. The pressure is then increased slowly until the first drop of water appears on the outside surface of the graft. The pressure, in psi, at which the water first appears is the WEP value.
Longitudinal Foreshortening (LFS).
Longitudinal foreshortening is a measurement of the amount by which the graft foreshortens upon radial expansion. A line is drawn along the length of every sample to be tested. The length of the line is measured both before and after radial expansion and the change in length is converted into a percentage b;y dividing the difference between initial and final lengths and dividing by the initial length.
Radial Eanansion Protocol and Test Results.
The following ePTFE grafts were selected for radial expansion testing and characterization:
6 mm m Regular Wall ePTFE Graft (IMPRA Lot 34396).
3 mm m Thin Wall ePTFE Graft (llVIPRA Lot 34391 ).
. 3 mm rePTFE Graft (ERF 1683).
3 mm rePTFE Graft (ERF 1687).
3 mm rePTFE Graft (ERF 1689).
3 mm rePTFE Encapsulated Graft (ERF~,~).
Each of the foregoing samples were radiailly expanded using commercially available angioplasty balloon catheters. Radial expansion was conducted in a water tank held at a constant temperature of 37° C maintained by a circulation pump and heater apparatus. An electric gear pump (Micropump INTEGRAL Series Model No. HGR004) connected to a variable DC voltage supply was used to provide the required fluid pressure to inflate the balloons. A bypass valve was set to bypass expansion flow if pressures above the rated burst pressure of the balloon were reached. Radial expansion was conducted using balloon catheters as follows:
3 mm Grafts (a) 9 mm expansion (3X) using a 9 mm x 8 cm long angioplasty balloon catheter.
(b) 12 mm expansion (4X) using a 12 mm x 8 cm long angioplasty balloon catheter.
(c) 15 mm expansion (5X) using a 15 mm x 8 cm long angioplasty balloon catheter.
6 mm Graft (a) 18 mm expansion (3X) using a 18 mm x 8 crn long angioplasty balloon catheter.
(b) 24 mm expansion (4X) using a 24 mm x 8 cm long angioplasty balloon catheter.
(c) 30 mm expansion (5X) using a 30 mm x 5 cm long angioplasty balloon catheter.
Each graft sample length (70-80 cm) was cut into 2 halves. A first was used for base graft testing and the second half was used for radial expansion. The second half for radial expansion was again cut into three 12 cm sections and each section was numbered with the graft number and an identifier indicating which test it was to be used for, e.g., 3X, 4X or SX expansion. Each segment was then radiaIly expanded to the maximum balloon diameter in the water bath then held for 1 minute. For the larger expansion ratios, i.e., SX, it was necessary to pre-expand the graft in order to permit the graft lumen to accept the larger profile balloon. After radial expansion, the balloon was deflated, and the graft removed and set aside for testing.

Tables 3-7 set forth the averaged raw data obtained from testing a 6 mm m standard PTFE vascular graft (Lot 34396, IIVVIPRA, Inc., Tempe, Arizona), a 3 mm ID
standard PTFE vascular graft (Lot 34391, IMPRA, Inc. Tempe Arizona), and the inventive rePTFE graRs, ERF 1683, ERF 1687, and ERF 1689. Figures 13A-24C are the scanning electron micrographs taken of the inner surface and the outer surface of each of the grafts for which the test data in Tables 4-7 is reflected.

Graft: ILot 34396 6 mm ID RW P'TFE
Graft Base 3X ~ 4X ! 5X

IND ~ 3311.3 31f1.0 ~ 3310.9 ~ 3210.9 IND ~ 30 t 1.2 30 t 1.4 I 3I1 0.7 31 t 0.8 WEP 5.410.23 ~ 5.38 ~ 0.53 610.52 8.~ t 1.0 WT 0.72 x.003 0.510.03.2 ~ 0.36 t 0.270.33 t 0.14 ~

RTS ' 1143 t 966 879 f 80.6 897 t 310.81110 t 196.5 FSHT % n/a l.St2.3~G ! 4.73.11 3.~~2.40 ~

I Graft:
I Lot I 3mm TW PTFE
Graft Base 3X 4X ~ 5X

IND I 3310.8 33 f 0.8 3210.5 3310.9 IND 3111.2 31f1.2 310.8 2910.9 WEP ~ S.S t 0.48S.S t 0.29 5.810.42 ~
6.210.6 WT i 0.38 ~ .005 0.2910.009 0.25 t 0.005 ~ I 0.23 t 0.007 RTS t 1321 1311.1 856 ~ 249.9 9 ~ 177.9 !
~ 880 t 187.3 FSHT % n/a 3.5 ~ 2.43 3.5 t 2.42 ~ 3.0 t 2 E craft:
I
ERF

I
3mm TW

Base 3X 4X 5X

IND 16.4 15.8 17.5 15 IW ~a 14.3 12.5 16.5 ~P 8.08 8.67 9.33 ~ 7.97 i 0.37 0.37 0.26 0.19 RTS I 487.02 632.59 1007.16 1051.15 j FSHT % n/a n/a n/a ~ n/a WO 98/33453 PCT/~JS98/02361 I Graft: I ERF 1687 I 3 mm TW I
Base 3X 4X ' SX

I1~1D _ 39 42.5 39.3 22.4 IND n/a 32.5 33.5 36 WEP 4.06 4.53 5.07 5.43 WT 0.39 0.14 0.08 0.07 RTS 749 791.86 1016.54 ~ 1550.65 FSHT %) n/a n/a n/a ' n/a Graft: s ERF 1689 I
3 mm TW
..

Base 3X ~ 4X SX

IND ~ 18.2 22.5 26.8 ~ 25 IND. ~ n/a 17.5 ~ 23.5 22. ~

WEP 5.14 5.97 6.74 6.5 7 WT 0.388 0.13 0.11 I 0.08 RTS 667.2 791.86 1017 ' 1550.65 FSHT % n/a n/a n/a ! n/a It is significant to note, paradoxically, that despite the decreases in node density and in fibril density observed as a result of increased degrees of radial expansion, the water entry pressure of the radially expanded graft increases as the graft is radially expanded. The increase in WEP values, as a function of radial expansion, is the result of the increased tortuosity of the rePTFE material microstructure as it is radially expanded from its original diameter to its expanded diameter in each of the rePTFE samples tested.
It will be seen and appreciated by those skilled in the art that an inventive rePTFE
tubular graft suitable for endoluminal radial expansion at applied pressures of less than 6 atm has been described with reference to its preferred embodiments and with reference to an inventive method for making the rePTFE tubular endoluminal grafts. The inventive rePTFE
tubular grafts each consist of a longitudinally expanded polytetrafluoroethylene tubular member having a continuous substantially concentric wall surface which has no seam and which is radially deformable between about 50% to about 700% its original diameter with application of a radially directed outward pressure of less than about 6 atm without loss of structural integrity. Structural integrity is considered retained where the microstructure of the ePTFE after radial expansion is substantially flee of broken or fractured fibrils and where the following factors are met: 1 ) IND remains substantially the same as the unexpended graft; 2) water entry pressure as measured by Association for the Advancement of Medical Instrumentation (AAMI) test method 8.2.4 remains within t 60% of the water entry pressure of the unexpended graft; 3) the wall thickness of the graft, as determined by AAMI test method 8.7.4, maintains its concentricity as determined by a substantially uniform wall thickness within X30% about the circumference of the graft; 4) average post-radial expansion wall thickness remains within about X70% of the average pre-radial expansion wall thickness as determined by AA1V>JI test method 8.7.4; 5) longitudinal tensile strength as AAMI test method 8.3.2 remains witlun ~ 100% of the value of the unexpended graft, when normalized for wall thickness; 6) radis~l tensile strength as measured by AAMI
test method 8.3.1 remains within t 40% of the value of the unexpended graft, when normalized for wall thickness; and 7) is free of gross tears or fractures.

Claims (12)

  1. WHAT IS CLAIMED IS:
    A continuous tubular structure comprising an expanded polytetrafluoroethylen material having a microstructure characterized by a plurality of nodes interconnected by fibrils, the fibrils having an orientation substantially parallel to the longitudinal axis of the polytetrafluoroethylene tubular material and the nodes having a longitudinal axis substantially perpendicular to the longitudinal axis of the polytetrafluoroethylene material, the polytetrafluoroethylene tubular material being capable of undergoing radial deformation under the influence of a positive pressure applied through the lumen of the polytetrafluoroethylene tubular material and radially outward therefrom which causes a plurality of the nodes in the microstructure to undergo elongation along the longitudinal axis of the nodes, while substantially retaining an average internodal distance throughout the microstructure of the section of polytetrafluoroethylene tubular material which is radially deformed, wherein the expanded polytetrafluoroethylene is radially deformable to at least 50%
    its original diameter at applied positive pressures less than about 6 atm.
  2. 2. The continuous tubular structure according to claim 1, wherein the expanded polytetrafluoroethylen tubular material is radially deformable between about 50% to 700% its original diameter without loss of structure integrity.
  3. 3. The continuous tubular structure according to claim 2, wherein the expanded polytetrafluoroethylene is radially deformable.to between 50% to 700% its original diameter with water entry pressure remaining within +60% of the water entry pressure value of the non-deformed graft.
  4. 4. The continuous tubular structure according to claim 2, wherein the expanded polytetrafluoroethylene is radially deformable to between 50% to 700% its original diameter wherein wall thickness of the graft maintains its concentricity and is free of gross tears or fractures.
  5. 5. The continuos tubular structure according to claim 2, wherein the expanded polytetrafluoroethylene is radially deformable to between 50% to 700% its original diameter wherein longitudinal tensile strength remains within ~100% of the value of the unexpanded graft.
  6. 6. The continuous tubular structure according to claim 2, wherein the expanded polytetrafluoroethylene is radially deformable to between 50% to 700% its original diameter wherein radial tensile strength remains within ~40% of the value of the unexpanded graft.
  7. 7. The continuous tubular structure according to claim 2, wherein the expanded polytetrafluoroethylene is radially deformable to between 50% to 700% its original diameter wherein average nodal elongation in the radially deformed graft is no more than about 300% the average node length of the unexpanded graft.
  8. 8. The continuous tubular structure according to claim 2, further including a radially expandable stent member concentrically positioned within the lumen of the tubular structure.
  9. 9. The continuous tubular structure according to claim 8, wherein the radially expandable stent member is selected from the group of stents consisting of balloon expandable, self expanding and memory shape stent members.
  10. 10. The continuous tubular structure according to claim 8, further including a second continuous tubular structure comprised of polytetrafluoroethylen concentrically positioned with the lumen of the stent member and in intimate contact with the stent member and the continuous tubular structure.
  11. 11. The continuous tubular structure according to claim 1, further including a radially expandable stent member concentrically positioned about at least one of an outer, abluminal surface and a lumen surface of the continuous tubular structure.
  12. 12. The continuous tubular structure according to claim 11, wherein the radially expandable stent member is selected from the group of stents consisting of balloon expandable, self expanding, and shape memory stent members.
CA002279974A 1997-02-05 1998-02-02 Radially expandable tubular polytetrafluoroethylene grafts and method of making same Expired - Lifetime CA2279974C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002565930A CA2565930A1 (en) 1997-02-05 1998-02-02 Radially expandable tubular polytetrafluoroethylene grafts and method of making same

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/794,871 1997-02-05
US08/794,871 US6039755A (en) 1997-02-05 1997-02-05 Radially expandable tubular polytetrafluoroethylene grafts and method of making same
PCT/US1998/002361 WO1998033453A2 (en) 1997-02-05 1998-02-02 Radially expandable tubular polytetrafluoroethylene grafts and method of making same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002565930A Division CA2565930A1 (en) 1997-02-05 1998-02-02 Radially expandable tubular polytetrafluoroethylene grafts and method of making same

Publications (2)

Publication Number Publication Date
CA2279974A1 CA2279974A1 (en) 1998-08-06
CA2279974C true CA2279974C (en) 2007-05-01

Family

ID=25163937

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002279974A Expired - Lifetime CA2279974C (en) 1997-02-05 1998-02-02 Radially expandable tubular polytetrafluoroethylene grafts and method of making same

Country Status (8)

Country Link
US (1) US6039755A (en)
EP (3) EP1557258B1 (en)
JP (1) JP2001510367A (en)
AU (1) AU6149398A (en)
CA (1) CA2279974C (en)
DE (1) DE69829754T8 (en)
ES (2) ES2607878T3 (en)
WO (1) WO1998033453A2 (en)

Families Citing this family (145)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6264684B1 (en) * 1995-03-10 2001-07-24 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Helically supported graft
US6451047B2 (en) 1995-03-10 2002-09-17 Impra, Inc. Encapsulated intraluminal stent-graft and methods of making same
US6951572B1 (en) * 1997-02-20 2005-10-04 Endologix, Inc. Bifurcated vascular graft and method and apparatus for deploying same
US6395019B2 (en) 1998-02-09 2002-05-28 Trivascular, Inc. Endovascular graft
US6077296A (en) * 1998-03-04 2000-06-20 Endologix, Inc. Endoluminal vascular prosthesis
JP4377546B2 (en) * 1998-06-19 2009-12-02 エンドロジックス、インク Self-expanding branch lumen prosthesis
US6461380B1 (en) 1998-07-28 2002-10-08 Advanced Cardiovascular Systems, Inc. Stent configuration
US6547814B2 (en) * 1998-09-30 2003-04-15 Impra, Inc. Selective adherence of stent-graft coverings
US6733523B2 (en) 1998-12-11 2004-05-11 Endologix, Inc. Implantable vascular graft
US6187036B1 (en) 1998-12-11 2001-02-13 Endologix, Inc. Endoluminal vascular prosthesis
JP4189127B2 (en) 1998-12-11 2008-12-03 エンドロジックス、インク Intraluminal artificial blood vessels
US6660030B2 (en) * 1998-12-11 2003-12-09 Endologix, Inc. Bifurcation graft deployment catheter
US7637886B2 (en) * 1999-01-25 2009-12-29 Atrium Medical Corporation Expandable fluoropolymer device and method of making
US7018401B1 (en) 1999-02-01 2006-03-28 Board Of Regents, The University Of Texas System Woven intravascular devices and methods for making the same and apparatus for delivery of the same
US6398803B1 (en) 1999-02-02 2002-06-04 Impra, Inc., A Subsidiary Of C.R. Bard, Inc. Partial encapsulation of stents
US6855159B1 (en) * 1999-02-05 2005-02-15 Eva Corporation Surgical guide line assembly and separator assembly for use during a surgical procedure
US6261316B1 (en) 1999-03-11 2001-07-17 Endologix, Inc. Single puncture bifurcation graft deployment system
US8034100B2 (en) 1999-03-11 2011-10-11 Endologix, Inc. Graft deployment system
US6440161B1 (en) 1999-07-07 2002-08-27 Endologix, Inc. Dual wire placement catheter
US6402779B1 (en) * 1999-07-26 2002-06-11 Endomed, Inc. Balloon-assisted intraluminal stent graft
US6342294B1 (en) * 1999-08-12 2002-01-29 Bruce G. Ruefer Composite PTFE article and method of manufacture
US10172730B2 (en) * 1999-11-19 2019-01-08 Vactronix Scientific, Llc Stents with metallic covers and methods of making same
US7736687B2 (en) * 2006-01-31 2010-06-15 Advance Bio Prosthetic Surfaces, Ltd. Methods of making medical devices
US6537310B1 (en) * 1999-11-19 2003-03-25 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal implantable devices and method of making same
US6866686B2 (en) * 2000-01-28 2005-03-15 Cryolife, Inc. Tissue graft
US6616689B1 (en) 2000-05-03 2003-09-09 Advanced Cardiovascular Systems, Inc. Intravascular stent
US6821295B1 (en) 2000-06-26 2004-11-23 Thoratec Corporation Flared coronary artery bypass grafts
US6808533B1 (en) 2000-07-28 2004-10-26 Atrium Medical Corporation Covered stent and method of covering a stent
US6773454B2 (en) 2000-08-02 2004-08-10 Michael H. Wholey Tapered endovascular stent graft and method of treating abdominal aortic aneurysms and distal iliac aneurysms
JP4215505B2 (en) 2000-11-22 2009-01-28 バード・ペリフェラル・バスキュラー・インコーポレーテッド High density microwalled expanded polytetrafluoroethylene tubular structure
DE10061936A1 (en) * 2000-12-13 2002-07-04 Valentin Kramer Object from ePTFE and method of manufacturing the same
US6929660B1 (en) 2000-12-22 2005-08-16 Advanced Cardiovascular Systems, Inc. Intravascular stent
US6641607B1 (en) 2000-12-29 2003-11-04 Advanced Cardiovascular Systems, Inc. Double tube stent
IL157729A0 (en) * 2001-03-20 2004-03-28 Gmp Cardiac Care Inc Rail stent
US6756007B2 (en) * 2001-04-04 2004-06-29 Bard Peripheral Vascular, Inc. Method for preparing an implantable prosthesis for loading into a delivery apparatus
US6939373B2 (en) * 2003-08-20 2005-09-06 Advanced Cardiovascular Systems, Inc. Intravascular stent
US6629994B2 (en) * 2001-06-11 2003-10-07 Advanced Cardiovascular Systems, Inc. Intravascular stent
US6635083B1 (en) 2001-06-25 2003-10-21 Advanced Cardiovascular Systems, Inc. Stent with non-linear links and method of use
US6749629B1 (en) 2001-06-27 2004-06-15 Advanced Cardiovascular Systems, Inc. Stent pattern with figure-eights
US6716239B2 (en) 2001-07-03 2004-04-06 Scimed Life Systems, Inc. ePTFE graft with axial elongation properties
WO2003053288A1 (en) * 2001-12-20 2003-07-03 Trivascular, Inc. Advanced endovascular graft
US7147661B2 (en) 2001-12-20 2006-12-12 Boston Scientific Santa Rosa Corp. Radially expandable stent
US7288111B1 (en) * 2002-03-26 2007-10-30 Thoratec Corporation Flexible stent and method of making the same
US6656220B1 (en) 2002-06-17 2003-12-02 Advanced Cardiovascular Systems, Inc. Intravascular stent
MXPA05001845A (en) * 2002-08-15 2005-11-17 Gmp Cardiac Care Inc Stent-graft with rails.
AU2003290881A1 (en) * 2002-11-15 2004-06-15 Gmp Cardiac Care, Inc. Rail stent
US6929663B2 (en) * 2003-03-26 2005-08-16 Boston Scientific Scimed, Inc. Longitudinally expanding medical device
DE602004024053D1 (en) 2003-05-07 2009-12-24 Advanced Bio Prothestic Surfac METALLIC IMPLANTABLE PROSTHESIS AND MANUFACTURING METHOD THEREFOR
US7448122B1 (en) * 2003-10-31 2008-11-11 Advanced Cardiovascular Systems, Inc. Method of compressing a polymeric layer of an expandable medical device
JP5132153B2 (en) * 2003-12-30 2013-01-30 ボストン サイエンティフィック リミテッド Uniaxial stretching of fluoropolymer products
US7418464B2 (en) * 2004-01-27 2008-08-26 International Business Machines Corporation Method, system, and program for storing data for retrieval and transfer
US7803178B2 (en) * 2004-01-30 2010-09-28 Trivascular, Inc. Inflatable porous implants and methods for drug delivery
AU2005211243A1 (en) 2004-02-03 2005-08-18 Atria Medical Inc. Device and method for controlling in-vivo pressure
EP1753367A4 (en) * 2004-03-11 2011-10-12 Trivascular Inc Modular endovascular graft
US8377110B2 (en) * 2004-04-08 2013-02-19 Endologix, Inc. Endolumenal vascular prosthesis with neointima inhibiting polymeric sleeve
US7309461B2 (en) * 2004-04-12 2007-12-18 Boston Scientific Scimed, Inc. Ultrasonic crimping of a varied diameter vascular graft
AU2005237985B2 (en) * 2004-04-20 2010-10-21 Genzyme Corporation Surgical mesh-like implant
US7955373B2 (en) * 2004-06-28 2011-06-07 Boston Scientific Scimed, Inc. Two-stage stent-graft and method of delivering same
US8778256B1 (en) 2004-09-30 2014-07-15 Advanced Cardiovascular Systems, Inc. Deformation of a polymer tube in the fabrication of a medical article
EP1791496B1 (en) * 2004-08-31 2019-07-31 C.R. Bard, Inc. Self-sealing ptfe graft with kink resistance
US8029563B2 (en) 2004-11-29 2011-10-04 Gore Enterprise Holdings, Inc. Implantable devices with reduced needle puncture site leakage
US7806922B2 (en) * 2004-12-31 2010-10-05 Boston Scientific Scimed, Inc. Sintered ring supported vascular graft
US7857843B2 (en) * 2004-12-31 2010-12-28 Boston Scientific Scimed, Inc. Differentially expanded vascular graft
US7524445B2 (en) * 2004-12-31 2009-04-28 Boston Scientific Scimed, Inc. Method for making ePTFE and structure containing such ePTFE, such as a vascular graft
US20060224226A1 (en) * 2005-03-31 2006-10-05 Bin Huang In-vivo radial orientation of a polymeric implantable medical device
US20060233990A1 (en) 2005-04-13 2006-10-19 Trivascular, Inc. PTFE layers and methods of manufacturing
US20060233991A1 (en) 2005-04-13 2006-10-19 Trivascular, Inc. PTFE layers and methods of manufacturing
JP2008543376A (en) * 2005-06-08 2008-12-04 シー・アール・バード・インコーポレーテッド Grafts and stents with inorganic biocompatible calcium salts
PT1890641T (en) * 2005-06-17 2017-05-30 Bard Inc C R Vascular graft with kink resistance after clamping
ES2574780T3 (en) * 2005-09-06 2016-06-22 C.R. Bard, Inc. Drug Release Graft
CA2626598A1 (en) 2005-11-09 2007-05-18 C.R. Bard Inc. Grafts and stent grafts having a radiopaque marker
US20070160672A1 (en) * 2006-01-06 2007-07-12 Vipul Bhupendra Dave Methods of making bioabsorbable drug delivery devices comprised of solvent cast films
US20070162110A1 (en) * 2006-01-06 2007-07-12 Vipul Bhupendra Dave Bioabsorbable drug delivery devices
US20070158880A1 (en) * 2006-01-06 2007-07-12 Vipul Bhupendra Dave Methods of making bioabsorbable drug delivery devices comprised of solvent cast tubes
US9681948B2 (en) 2006-01-23 2017-06-20 V-Wave Ltd. Heart anchor device
US20070191926A1 (en) * 2006-02-14 2007-08-16 Advanced Cardiovascular Systems, Inc. Stent pattern for high stent retention
WO2007098937A1 (en) * 2006-02-28 2007-09-07 Angiomed Gmbh & Co. Medizintechnik Kg Flexible stretch stent-graft
AU2007249229B2 (en) * 2006-05-12 2013-05-23 Cardinal Health 529, Llc Balloon expandable bioabsorbable drug eluting flexible stent
US20080071343A1 (en) * 2006-09-15 2008-03-20 Kevin John Mayberry Multi-segmented graft deployment system
US8778009B2 (en) * 2006-10-06 2014-07-15 Abbott Cardiovascular Systems Inc. Intravascular stent
US9198749B2 (en) * 2006-10-12 2015-12-01 C. R. Bard, Inc. Vascular grafts with multiple channels and methods for making
CN103767810B (en) 2006-10-22 2016-06-15 Idev科技公司 From the manufacturing process of extendable bracket
KR101659197B1 (en) 2006-10-22 2016-09-22 이데브 테크놀로지스, 아이엔씨. Devices and methods for stent advancement
US10188534B2 (en) * 2006-11-17 2019-01-29 Covidien Lp Stent having reduced passage of emboli and stent delivery system
US8523931B2 (en) * 2007-01-12 2013-09-03 Endologix, Inc. Dual concentric guidewire and methods of bifurcated graft deployment
US8388679B2 (en) 2007-01-19 2013-03-05 Maquet Cardiovascular Llc Single continuous piece prosthetic tubular aortic conduit and method for manufacturing the same
US8814930B2 (en) 2007-01-19 2014-08-26 Elixir Medical Corporation Biodegradable endoprosthesis and methods for their fabrication
FR2915903B1 (en) 2007-05-10 2010-06-04 Carpentier Matra Carmat METHOD FOR THE PRODUCTION OF A HEMOCOMPATIBLE OBJECT OF COMPLEX CONFIGURATION AND OBJECT THUS OBTAINED
US7972373B2 (en) * 2007-12-19 2011-07-05 Advanced Technologies And Regenerative Medicine, Llc Balloon expandable bioabsorbable stent with a single stress concentration region interconnecting adjacent struts
US8221494B2 (en) 2008-02-22 2012-07-17 Endologix, Inc. Apparatus and method of placement of a graft or graft system
US8196279B2 (en) * 2008-02-27 2012-06-12 C. R. Bard, Inc. Stent-graft covering process
US8236040B2 (en) 2008-04-11 2012-08-07 Endologix, Inc. Bifurcated graft deployment systems and methods
JP5134729B2 (en) 2008-07-01 2013-01-30 エンドロジックス、インク Catheter system
FR2938111B1 (en) * 2008-11-06 2012-08-03 Axoncable ELECTRICAL WIRE WITH LOW DIELECTRIC CONECTANT PTFE SHEATH, AND METHOD AND TOOL FOR MANUFACTURING THE SAME
US11219706B2 (en) 2009-03-11 2022-01-11 Arrow International Llc Enhanced formulations for coating medical devices
EP2429452B1 (en) 2009-04-28 2020-01-15 Endologix, Inc. Endoluminal prosthesis system
US9579103B2 (en) * 2009-05-01 2017-02-28 Endologix, Inc. Percutaneous method and device to treat dissections
US10772717B2 (en) 2009-05-01 2020-09-15 Endologix, Inc. Percutaneous method and device to treat dissections
US10076403B1 (en) 2009-05-04 2018-09-18 V-Wave Ltd. Shunt for redistributing atrial blood volume
US9034034B2 (en) 2010-12-22 2015-05-19 V-Wave Ltd. Devices for reducing left atrial pressure, and methods of making and using same
WO2010128501A1 (en) 2009-05-04 2010-11-11 V-Wave Ltd. Device and method for regulating pressure in a heart chamber
US20210161637A1 (en) 2009-05-04 2021-06-03 V-Wave Ltd. Shunt for redistributing atrial blood volume
US8491646B2 (en) 2009-07-15 2013-07-23 Endologix, Inc. Stent graft
WO2011017123A2 (en) 2009-07-27 2011-02-10 Endologix, Inc. Stent graft
US20110082327A1 (en) * 2009-10-07 2011-04-07 Manning Miles Goldsmith Saline membranous coupling mechanism for electromagnetic and piezoelectric round window direct drive systems for hearing amplification
US20110218617A1 (en) * 2010-03-02 2011-09-08 Endologix, Inc. Endoluminal vascular prosthesis
MY169594A (en) * 2010-04-22 2019-04-22 Biovic Sdn Bhd Expanded ptfe medical devices with spiraled ridges and process of manufacture thereof
US8696738B2 (en) 2010-05-20 2014-04-15 Maquet Cardiovascular Llc Composite prosthesis with external polymeric support structure and methods of manufacturing the same
US9023095B2 (en) 2010-05-27 2015-05-05 Idev Technologies, Inc. Stent delivery system with pusher assembly
US20120109279A1 (en) 2010-11-02 2012-05-03 Endologix, Inc. Apparatus and method of placement of a graft or graft system
WO2012068298A1 (en) 2010-11-17 2012-05-24 Endologix, Inc. Devices and methods to treat vascular dissections
US8696741B2 (en) 2010-12-23 2014-04-15 Maquet Cardiovascular Llc Woven prosthesis and method for manufacturing the same
CN105232195B (en) 2011-03-01 2018-06-08 恩朵罗杰克斯股份有限公司 Delivery catheter system
DE102011079680A1 (en) * 2011-07-22 2013-01-24 Aesculap Ag Coated implant and method for its manufacture
US11135054B2 (en) 2011-07-28 2021-10-05 V-Wave Ltd. Interatrial shunts having biodegradable material, and methods of making and using same
CA2855943C (en) 2011-07-29 2019-10-29 Carnegie Mellon University Artificial valved conduits for cardiac reconstructive procedures and methods for their production
CA3021799C (en) 2011-11-09 2022-03-15 Arrow International, Inc. Enhanced formulations for coating medical devices
CN105025943B (en) 2013-03-11 2020-07-10 泰利福医疗公司 Antithrombotic and antimicrobial treated devices
US9713696B2 (en) 2013-05-21 2017-07-25 V-Wave Ltd. Apparatus and methods for delivering devices for reducing left atrial pressure
US9814560B2 (en) 2013-12-05 2017-11-14 W. L. Gore & Associates, Inc. Tapered implantable device and methods for making such devices
US9855156B2 (en) 2014-08-15 2018-01-02 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9480588B2 (en) 2014-08-15 2016-11-01 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9259339B1 (en) 2014-08-15 2016-02-16 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US9730819B2 (en) 2014-08-15 2017-08-15 Elixir Medical Corporation Biodegradable endoprostheses and methods of their fabrication
US10569063B2 (en) 2014-10-03 2020-02-25 W. L. Gore & Associates, Inc. Removable covers for drug eluting medical devices
US10668257B2 (en) * 2014-10-16 2020-06-02 W. L. Gore & Associates, Inc. Blow molded composite devices and methods
WO2016115367A1 (en) * 2015-01-14 2016-07-21 Textiles Coated Incorporated Systems and methods for providing shaped composites that include fluoropolymer films
WO2016178171A1 (en) 2015-05-07 2016-11-10 The Medical Research Infrastructure And Health Services Fund Of The Tel-Aviv Medical Center Temporary interatrial shunts
EP3302619A1 (en) 2015-06-05 2018-04-11 W. L. Gore & Associates, Inc. A low bleed implantable prosthesis with a taper
US11129737B2 (en) 2015-06-30 2021-09-28 Endologix Llc Locking assembly for coupling guidewire to delivery system
WO2017151900A1 (en) * 2016-03-02 2017-09-08 Peca Labs, Inc. Expandable implantable conduit
EP3457985B1 (en) 2016-05-16 2021-02-17 Elixir Medical Corporation Uncaging stent
US11622872B2 (en) 2016-05-16 2023-04-11 Elixir Medical Corporation Uncaging stent
US10835394B2 (en) 2016-05-31 2020-11-17 V-Wave, Ltd. Systems and methods for making encapsulated hourglass shaped stents
US20170340460A1 (en) 2016-05-31 2017-11-30 V-Wave Ltd. Systems and methods for making encapsulated hourglass shaped stents
US11291807B2 (en) 2017-03-03 2022-04-05 V-Wave Ltd. Asymmetric shunt for redistributing atrial blood volume
EP3589238A1 (en) 2017-03-03 2020-01-08 V-Wave Ltd. Shunt for redistributing atrial blood volume
US10238513B2 (en) 2017-07-19 2019-03-26 Abbott Cardiovascular Systems Inc. Intravascular stent
WO2019142152A1 (en) 2018-01-20 2019-07-25 V-Wave Ltd. Devices and methods for providing passage between heart chambers
US10898698B1 (en) 2020-05-04 2021-01-26 V-Wave Ltd. Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same
US11458287B2 (en) 2018-01-20 2022-10-04 V-Wave Ltd. Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same
US11612385B2 (en) 2019-04-03 2023-03-28 V-Wave Ltd. Systems and methods for delivering implantable devices across an atrial septum
CN114096205A (en) 2019-05-20 2022-02-25 V-波有限责任公司 System and method for creating room shunt tubes
US11234702B1 (en) 2020-11-13 2022-02-01 V-Wave Ltd. Interatrial shunt having physiologic sensor
US11813386B2 (en) 2022-04-14 2023-11-14 V-Wave Ltd. Interatrial shunt with expanded neck region

Family Cites Families (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US31341A (en) * 1861-02-05 Improvement in rotary harrows
US612897A (en) * 1898-10-25 Construction of tubes and cylinders
US2642625A (en) * 1950-06-23 1953-06-23 Sprague Electric Co Process for producing thin polytetrahaloethylene films
US3060517A (en) * 1959-08-18 1962-10-30 Du Pont Fabrication of massive shaped articles of polytetrafluoroethylene
BE607748A (en) * 1960-09-02
US3281511A (en) * 1964-05-15 1966-10-25 Gen Plastics Corp Method of preparing microporous tetrafluoroethylene resin sheets
US3196194A (en) * 1964-06-04 1965-07-20 Pennsylvania Fluorocarbon Co I Fep-fluorocarbon tubing process
US3887761A (en) * 1967-09-07 1975-06-03 Gore & Ass Tape wrapped conductor
SE392582B (en) * 1970-05-21 1977-04-04 Gore & Ass PROCEDURE FOR THE PREPARATION OF A POROST MATERIAL, BY EXPANDING AND STRETCHING A TETRAFLUORETENE POLYMER PREPARED IN AN PASTE-FORMING EXTENSION PROCEDURE
US3767500A (en) * 1971-12-28 1973-10-23 Tme Corp Method of laminating long strips of various materials
US3992725A (en) * 1973-11-16 1976-11-23 Homsy Charles A Implantable material and appliances and method of stabilizing body implants
US6436135B1 (en) * 1974-10-24 2002-08-20 David Goldfarb Prosthetic vascular graft
US4061517A (en) * 1975-08-27 1977-12-06 Chemelec Products, Inc. Method of making fluorocarbon resin covered gaskets
JPS5360979A (en) 1976-11-11 1978-05-31 Daikin Ind Ltd Polytetrafluoroethylene fine powder and its preparation
US4416028A (en) * 1981-01-22 1983-11-22 Ingvar Eriksson Blood vessel prosthesis
US4604762A (en) * 1981-02-13 1986-08-12 Thoratec Laboratories Corporation Arterial graft prosthesis
US4596837A (en) * 1982-02-22 1986-06-24 Daikin Industries Ltd. Semisintered polytetrafluoroethylene article and production thereof
JPS59109534A (en) * 1982-12-14 1984-06-25 Nitto Electric Ind Co Ltd Porous polytetrafluoroethylene object
JPS59109506A (en) * 1982-12-14 1984-06-25 Daikin Ind Ltd Novel fine polytetrafluoroethylene powder
US4512338A (en) * 1983-01-25 1985-04-23 Balko Alexander B Process for restoring patency to body vessels
US4503569A (en) * 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US4647416A (en) * 1983-08-03 1987-03-03 Shiley Incorporated Method of preparing a vascular graft prosthesis
US4580568A (en) * 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4655769A (en) * 1984-10-24 1987-04-07 Zachariades Anagnostis E Ultra-high-molecular-weight polyethylene products including vascular prosthesis devices and methods relating thereto and employing pseudo-gel states
US5102417A (en) * 1985-11-07 1992-04-07 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4733665C2 (en) * 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
DE3640745A1 (en) * 1985-11-30 1987-06-04 Ernst Peter Prof Dr M Strecker Catheter for producing or extending connections to or between body cavities
JPS62279920A (en) * 1986-05-28 1987-12-04 Daikin Ind Ltd Porous heat-shrinkable tetrafluoroethylene polymer pipe and its manufacture
US5071609A (en) * 1986-11-26 1991-12-10 Baxter International Inc. Process of manufacturing porous multi-expanded fluoropolymers
US5061276A (en) * 1987-04-28 1991-10-29 Baxter International Inc. Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation
US4816339A (en) * 1987-04-28 1989-03-28 Baxter International Inc. Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation
US5171805A (en) * 1987-08-05 1992-12-15 Daikin Industries Ltd. Modified polytetrafluoroethylene and process for preparing the same
CA1322628C (en) * 1988-10-04 1993-10-05 Richard A. Schatz Expandable intraluminal graft
US5464438A (en) * 1988-10-05 1995-11-07 Menaker; Gerald J. Gold coating means for limiting thromboses in implantable grafts
US5078726A (en) * 1989-02-01 1992-01-07 Kreamer Jeffry W Graft stent and method of repairing blood vessels
US4969896A (en) * 1989-02-01 1990-11-13 Interpore International Vascular graft prosthesis and method of making the same
US4957669A (en) * 1989-04-06 1990-09-18 Shiley, Inc. Method for producing tubing useful as a tapered vascular graft prosthesis
JP2678945B2 (en) * 1989-04-17 1997-11-19 有限会社ナイセム Artificial blood vessel, method for producing the same, and substrate for artificial blood vessel
US5152782A (en) * 1989-05-26 1992-10-06 Impra, Inc. Non-porous coated ptfe graft
US4955899A (en) * 1989-05-26 1990-09-11 Impra, Inc. Longitudinally compliant vascular graft
DE3918736C2 (en) * 1989-06-08 1998-05-14 Christian Dr Vallbracht Plastic-coated metal mesh stents
US5084065A (en) * 1989-07-10 1992-01-28 Corvita Corporation Reinforced graft assembly
US5123917A (en) * 1990-04-27 1992-06-23 Lee Peter Y Expandable intraluminal vascular graft
US5578071A (en) * 1990-06-11 1996-11-26 Parodi; Juan C. Aortic graft
EP0461791B1 (en) * 1990-06-11 1997-01-02 Hector D. Barone Aortic graft and apparatus for repairing an abdominal aortic aneurysm
US5360443A (en) * 1990-06-11 1994-11-01 Barone Hector D Aortic graft for repairing an abdominal aortic aneurysm
US5122154A (en) * 1990-08-15 1992-06-16 Rhodes Valentine J Endovascular bypass graft
DK0546021T3 (en) * 1990-08-28 1996-03-18 Meadox Medicals Inc Self-supporting woven blood vessel graft
AR246020A1 (en) * 1990-10-03 1994-03-30 Hector Daniel Barone Juan Carl A ball device for implanting an intraluminous aortic prosthesis, for repairing aneurysms.
JPH0717314Y2 (en) * 1990-10-18 1995-04-26 ソン ホーヨン Self-expanding intravascular stent
US5163951A (en) * 1990-12-27 1992-11-17 Corvita Corporation Mesh composite graft
US5156620A (en) * 1991-02-04 1992-10-20 Pigott John P Intraluminal graft/stent and balloon catheter for insertion thereof
DE69210225T2 (en) * 1991-02-14 1996-12-05 Baxter Int Manufacturing process for flexible biological tissue transplant materials
CA2202800A1 (en) * 1991-04-11 1992-10-12 Alec A. Piplani Endovascular graft having bifurcation and apparatus and method for deploying the same
CA2074349C (en) * 1991-07-23 2004-04-20 Shinji Tamaru Polytetrafluoroethylene porous film and preparation and use thereof
US5354309A (en) * 1991-10-11 1994-10-11 Angiomed Ag Apparatus for widening a stenosis in a body cavity
US5282860A (en) * 1991-10-16 1994-02-01 Olympus Optical Co., Ltd. Stent tube for medical use
US5387235A (en) * 1991-10-25 1995-02-07 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm
US5211658A (en) * 1991-11-05 1993-05-18 New England Deaconess Hospital Corporation Method and device for performing endovascular repair of aneurysms
US5316023A (en) * 1992-01-08 1994-05-31 Expandable Grafts Partnership Method for bilateral intra-aortic bypass
SE469653B (en) * 1992-01-13 1993-08-16 Lucocer Ab POROEST IMPLANT
US5405377A (en) * 1992-02-21 1995-04-11 Endotech Ltd. Intraluminal stent
US5591224A (en) * 1992-03-19 1997-01-07 Medtronic, Inc. Bioelastomeric stent
US5354329A (en) * 1992-04-17 1994-10-11 Whalen Biomedical, Inc. Vascular prosthesis having enhanced compatibility and compliance characteristics
US5540712A (en) * 1992-05-01 1996-07-30 Nitinol Medical Technologies, Inc. Stent and method and apparatus for forming and delivering the same
US5507771A (en) * 1992-06-15 1996-04-16 Cook Incorporated Stent assembly
US5429869A (en) * 1993-02-26 1995-07-04 W. L. Gore & Associates, Inc. Composition of expanded polytetrafluoroethylene and similar polymers and method for producing same
US5382261A (en) * 1992-09-01 1995-01-17 Expandable Grafts Partnership Method and apparatus for occluding vessels
US5383926A (en) * 1992-11-23 1995-01-24 Children's Medical Center Corporation Re-expandable endoprosthesis
US5453235A (en) 1993-01-29 1995-09-26 Impra, Inc. Method of forming dual porosity FTFE tubes by extrusion of concentric preforms
US5433996A (en) * 1993-02-18 1995-07-18 W. L. Gore & Associates, Inc. Laminated patch tissue repair sheet material
US5334201A (en) * 1993-03-12 1994-08-02 Cowan Kevin P Permanent stent made of a cross linkable material
US5464449A (en) * 1993-07-08 1995-11-07 Thomas J. Fogarty Internal graft prosthesis and delivery system
JPH09501585A (en) * 1993-08-18 1997-02-18 ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド Thin and seamless porous polytetrafluoroethylene tube
US6027779A (en) * 1993-08-18 2000-02-22 W. L. Gore & Associates, Inc. Thin-wall polytetrafluoroethylene tube
US5735892A (en) * 1993-08-18 1998-04-07 W. L. Gore & Associates, Inc. Intraluminal stent graft
JP2739420B2 (en) * 1993-09-03 1998-04-15 株式会社人工血管技術研究センター Artificial blood vessel
JPH07102413A (en) * 1993-09-16 1995-04-18 Japan Gore Tex Inc Polytetrafluoroethylene filament
US5389106A (en) * 1993-10-29 1995-02-14 Numed, Inc. Impermeable expandable intravascular stent
US5527353A (en) * 1993-12-02 1996-06-18 Meadox Medicals, Inc. Implantable tubular prosthesis
JP2703510B2 (en) * 1993-12-28 1998-01-26 アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド Expandable stent and method of manufacturing the same
US5549663A (en) * 1994-03-09 1996-08-27 Cordis Corporation Endoprosthesis having graft member and exposed welded end junctions, method and procedure
US5449373A (en) * 1994-03-17 1995-09-12 Medinol Ltd. Articulated stent
CA2193983C (en) * 1994-06-27 2005-07-26 William M. Colone Radially expandable polytetrafluoroethylene and expandable endovascular stents formed therewith
US5527355A (en) * 1994-09-02 1996-06-18 Ahn; Sam S. Apparatus and method for performing aneurysm repair
US5522883A (en) * 1995-02-17 1996-06-04 Meadox Medicals, Inc. Endoprosthesis stent/graft deployment system
US5556414A (en) * 1995-03-08 1996-09-17 Wayne State University Composite intraluminal graft
EP0814729B1 (en) * 1995-03-10 2000-08-09 Impra, Inc. Endoluminal encapsulated stent and methods of manufacture
US5591197A (en) * 1995-03-14 1997-01-07 Advanced Cardiovascular Systems, Inc. Expandable stent forming projecting barbs and method for deploying
US5641373A (en) * 1995-04-17 1997-06-24 Baxter International Inc. Method of manufacturing a radially-enlargeable PTFE tape-reinforced vascular graft
US5591228A (en) * 1995-05-09 1997-01-07 Edoga; John K. Methods for treating abdominal aortic aneurysms
EP0850030B1 (en) * 1995-08-24 2004-07-21 Bard Peripheral Vascular, Inc. Method of assembly of a covered endoluminal stent
JP5985277B2 (en) * 2012-05-08 2016-09-06 日東電工株式会社 Polytetrafluoroethylene porous membrane and waterproof ventilation member

Also Published As

Publication number Publication date
DE69829754D1 (en) 2005-05-19
CA2279974A1 (en) 1998-08-06
US6039755A (en) 2000-03-21
AU6149398A (en) 1998-08-25
EP1003440B1 (en) 2005-04-13
WO1998033453A2 (en) 1998-08-06
JP2001510367A (en) 2001-07-31
EP2295007A3 (en) 2015-08-12
EP1003440A2 (en) 2000-05-31
EP2295007A2 (en) 2011-03-16
ES2241119T3 (en) 2005-10-16
EP1557258A3 (en) 2015-01-07
EP1557258A2 (en) 2005-07-27
EP1557258B1 (en) 2016-10-05
DE69829754T8 (en) 2006-06-08
ES2607878T3 (en) 2017-04-04
DE69829754T2 (en) 2006-03-02
WO1998033453A3 (en) 1998-09-17

Similar Documents

Publication Publication Date Title
CA2279974C (en) Radially expandable tubular polytetrafluoroethylene grafts and method of making same
CA2193983C (en) Radially expandable polytetrafluoroethylene and expandable endovascular stents formed therewith
EP1148838B1 (en) A method of making large diameter vascular prosthesis and a vascular prosthesis made by said method
US7354449B2 (en) Covered stent and method of covering a stent
CA2243477C (en) A radially supported polytetrafluoroethylene vascular graft
US5735892A (en) Intraluminal stent graft
JP2001526080A (en) Supported implant and method of making same
MXPA01003281A (en) Selective adherence of stent-graft coverings, mandrel and method of making stent-graft device.
JPH10505266A (en) Asymmetric porous polytetrafluoroethylene molded article and method for producing the same
EP1767169B1 (en) Tubular stent-graft composite device and method of manufacture
JP2000503874A (en) Radially supported polytetrafluoroethylene vascular graft

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20180202